Automatic Shelf Registration Statement for Securities of a Well-Known Seasoned Issuer — Form S-3 Filing Table of Contents
Document/ExhibitDescriptionPagesSize 1: S-3ASR Orbital Sciences Corporation HTML 522K
2: EX-5.1 Opinion re: Legality HTML 19K
3: EX-8.1 Opinion re: Tax Matters HTML 13K
5: EX-23.1 Consent of Experts or Counsel HTML 6K
6: EX-25.1 Statement re: Eligibility of Trustee -- Form T-1|2 HTML 33K
4: EX-12 Statement re: Computation of Ratios HTML 18K
Approximate date of commencement of proposed sale to the
public: From time to time after the effective
date of this registration statement.
If the only securities being registered on this form are being
offered pursuant to dividend or interest reinvestment plans,
please check the following
box. o
If any of the securities being registered on this form are to be
offered on a delayed or continuous basis pursuant to
Rule 415 under the Securities Act of 1933, other than
securities offered only in connection with dividend or interest
reinvestment plans, check the following
box. þ
If this form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act,
please check the following box and list the Securities Act
registration statement number of the earlier effective
registration statement for the same
offering. o
If this form is a post-effective amendment filed pursuant to
Rule 462(c) under the Securities Act, check the following
box and list the Securities Act registration statement number of
the earlier effective registration statement for the same
offering. o
If this form is a registration statement pursuant to General
Instruction I.D. or a post-effective amendment thereto that
shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the
following box. þ
If this form is a post-effective amendment to a registration
statement filed pursuant to General Instruction I.D. filed to
register additional securities or additional classes of
securities pursuant to Rule 413(b) under the Securities
Act, check the following box. o
CALCULATION OF REGISTRATION
FEE
Proposed
Maximum Offering
Proposed
Title of Each Class of
Amount to be
Price
Maximum Aggregate
Amount of
Securities to be Registered
Registered
per Unit
Offering Price (1)
Registration Fee
2.4375% Convertible Senior
Subordinated Notes due 2027
$143,750,000
100%
$143,750,000
$4,413.13
Common shares, par value
$0.01 per share(2)
7,634,088(3)
—
—
—(4)
Totals
—
—
$143,750,000
$4,413.13
(1)
Estimated solely for purposes of
calculating the registration fee pursuant to Rule 457(o) of
the Securities Act of 1933, as amended (the “Securities
Act”).
(2)
Each share is accompanied by a
preferred share purchase right pursuant to a rights agreement
between Orbital Sciences Corporation and BankBoston N.A., as
rights agent.
(3)
The net share settlement feature of
the notes requires us, upon conversion, to (i) settle up to
the full principal amount of the notes in cash (the
“principal return”), and (ii) if the conversion
value is greater than the principal return, pay an amount with a
value equal to the difference between the conversion value and
the principal return, which we refer to as the “net
amount,” which net amount may be paid, at our option, in
cash, common shares or a combination of cash and common shares.
As a result of this net amount settlement feature, we are unable
to determine at this time if any common shares will be issuable
upon conversion. Because of this uncertainty, we have elected to
register the maximum number of common shares of Orbital Sciences
Corporation that could be issuable upon conversion of the notes
at the maximum conversion rate of 53.1067 common shares per
$1,000 principal amount of notes. Pursuant to Rule 416 of
the Securities Act, this registration statement also covers such
additional common shares that may be issued from time to time
upon conversion of the notes as a result of the anti-dilution
provisions of the notes.
(4)
Pursuant to Rule 457(i) of the
Securities Act, there is no additional filing fee payable with
respect to the common shares issuable upon conversion of the
notes because no additional consideration will be received in
connection with the exercise of the conversion privilege.
Orbital Sciences Corporation
2.4375% Convertible
Senior Subordinated Notes due 2027
and Common Shares Issuable Upon Conversion
Thereof
We issued a total of $143.75 million aggregate principal
amount of our 2.4375% Convertible Senior Subordinated Notes
due 2027 in a private placement completed in December 2006. This
prospectus covers resales of the notes and our common shares
issuable upon conversion of the notes. We will not receive any
of the proceeds from the sale of the notes or the common shares
by the selling securityholders.
The notes bear interest at the rate of 2.4375% per year,
payable on January 15 and July 15 of each year, beginning
July 15, 2007. The notes will mature on January 15,2027. We may not redeem the notes prior to January 21,2014. However, on or after January 21, 2014, we may redeem
the notes in whole or in part for cash at 100% of the principal
amount of the notes to be redeemed plus accrued and unpaid
interest (including additional interest, if any). On
January 15, 2014, January 15, 2017 and
January 15, 2022, as well as following the occurrence of a
fundamental change, holders may require us to repurchase notes
in whole or in part for cash at 100% of the principal amount of
the notes to be repurchased plus accrued and unpaid interest
(including additional interest, if any). We issued the notes
only in registered form in denominations of $1,000.
The notes are convertible into our common shares, par value
$0.01 per share, which we refer to as the “common
shares,” at any time on or after January 15, 2026, but
prior to the close of business on the second business day prior
to the stated maturity date, and also under the following
circumstances: (i) if the closing sale price of the common
shares reaches a specified threshold over a specified time
period; (ii) if the trading price of the notes is below a
specified threshold for a specified time period; (iii) if
the notes have been called for redemption; or (iv) upon the
occurrence of the specified transactions described in this
prospectus. Upon conversion of notes we will deliver cash and
common shares, if any, with an aggregate value, which we refer
to as the “conversion value,” equal to the conversion
rate multiplied by the average price (as defined in this
prospectus) of common shares as follows: (i) an amount in
cash, which we refer to as the “principal return,”
equal to the lesser of (a) the principal amount of the
converted notes and (b) the conversion value; and
(ii) if the conversion value is greater than the principal
return, an amount with a value equal to the difference between
the conversion value and the principal return, which we refer to
as the “net amount.” The net amount may be paid, at
our option, in cash, common shares or a combination of cash and
common shares.
The initial conversion rate for each $1,000 principal amount of
notes is 40.8513 common shares. This is equivalent to an initial
conversion price of approximately $24.48 per common share.
For a discussion of the circumstances in which the conversion
rate will be subject to adjustment, see “Description of
Notes — Conversion Rate Adjustments” in this
prospectus. In addition, if certain fundamental changes occur
prior to January 21, 2014, and a holder elects to convert
notes in connection with such fundamental change, we will
increase the conversion rate in connection with such conversion.
Our common shares are listed on the New York Stock Exchange
under the symbol “ORB.” On March 23, 2007, the last
reported sale price for our common shares on the New York Stock
Exchange was $18.59 per share.
The notes are our general unsecured senior subordinated
obligations and rank junior in right of payment to all of our
other existing and future senior debt, including obligations
under our amended and restated credit agreement.
We do not intend to apply for listing of the notes on any
securities exchange or for inclusion of the notes in any
automated quotation system. The notes are designated for trading
in The PORTAL
Marketsm
of the National Association of Securities Dealers, Inc. Pursuant
to a registration rights agreement, we agreed to file this shelf
registration statement permitting the resale of the notes and
the common shares, if any, issued upon the conversion of the
notes. If we fail to comply with specified obligations under the
registration rights agreement, additional interest will be
payable on the notes.
The selling securityholders identified in this prospectus may
offer from time to time up to $143.75 million aggregate
principal amount of the notes and our common shares issuable
upon conversion of the notes. The notes and our shares of common
stock may be offered in market transactions, in negotiated
transactions or otherwise, and at prices and on terms which will
be determined by the then prevailing market price or at
negotiated prices directly or through a broker or brokers, who
may act as agent or as principal; or through a combination of
such methods of sale. See “Plan of
Distribution” on page 57 for additional information on
the methods of sale.
INVESTING IN THESE SECURITIES INVOLVES RISKS. SEE
“RISK FACTORS” BEGINNING ON PAGE 6 OF THIS
PROSPECTUS, AS WELL AS THE RISK FACTORS RELATING TO OUR BUSINESS
THAT ARE INCORPORATED BY REFERENCE IN THIS PROSPECTUS FROM OUR
ANNUAL REPORT ON
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2006.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE
SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE
SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR
COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.
You should rely only on the information contained or
incorporated by reference in this prospectus. We have not
authorized anyone to provide you with different or additional
information. If anyone provides you with different or additional
information, you should not rely on it. The selling stockholders
are not making an offer to sell these securities in any
jurisdiction where the offer or sale is not permitted. The
information appearing in this prospectus and the documents
incorporated by reference herein is accurate only as of their
respective dates or on other dates which are specified in those
documents. Our business, financial condition, results of
operations and prospects may have changed since those dates.
This prospectus is part of a registration statement that we
filed with the Securities and Exchange Commission (the
“SEC”), using a “shelf” registration process
for the delayed offering and sale of securities pursuant to
Rule 415 under the Securities Act of 1933, as amended (the
“Securities Act”). Under the shelf process, the
selling securityholders may, from time to time, sell the offered
securities described in this prospectus in one or more
offerings. Additionally, under the shelf process, in certain
circumstances, we may provide a prospectus supplement that will
contain specific information about the terms of a particular
offering by one or more securityholders. We may also provide a
prospectus supplement to add information to, or update or change
information contained in, this prospectus.
This prospectus and any accompanying prospectus supplement do
not contain all of the information included in the registration
statement. We have omitted parts of the registration statement
in accordance with the rules and regulations of the SEC. For
further information, we refer you to the registration statement
on
Form S-3
of which this prospectus is a part, including its exhibits.
Statements contained in this prospectus and any accompanying
prospectus supplement about the provisions or contents of any
agreement or other document are not necessarily complete. If the
SEC’s rules and regulations require that an agreement or
document be filed as an exhibit to the registration statement,
please see that agreement or document for a complete description
of these matters.
You should read this prospectus together with any additional
information you may need to make your investment decision. You
should also read and carefully consider the information in the
documents we have referred you to in “Where You Can Find
Additional Information” and “Incorporation of Certain
Documents by Reference” below. Information incorporated by
reference after the date of this prospectus may add, update or
change information contained in this prospectus. Any information
in such subsequent filings that is inconsistent with this
prospectus will supersede the information in this prospectus or
any earlier prospectus supplement.
As used in this prospectus, unless the context otherwise
requires, the terms “we,”“us,”“our” and “the Company” mean, collectively,
Orbital Sciences Corporation and its subsidiaries and their
predecessors. All references to “common shares” refer
to our common stock, par value $.01 per share.
We file annual, quarterly and current reports, proxy statements
and other information with the SEC. Our SEC filings are
available over the Internet at the SEC’s website at
http://www.sec.gov. You may also read and copy any document we
file with the SEC at its public reference facilities:
Public Reference Room
100 F. Street, N.E.
Room 1580
Washington, DC 20549
You may also obtain information on the operation of the
SEC’s Public Reference Room by calling the SEC at
(800) SEC-0330.
Reports, proxy statements and other information concerning us
may also be inspected at the offices of the New York Stock
Exchange, which are located at 20 Broad Street, New York,
NY10005.
We are incorporating by reference certain information into this
prospectus. This means that we are disclosing important
information to you by referring you to other documents filed
separately with the SEC. The information incorporated by
reference is considered to be a part of this prospectus, and the
information we file later with the SEC will automatically update
and supersede the information filed earlier. We incorporate by
reference the documents listed below and any future filings we
make with the SEC under
Section 13(a), 13(c), 14 or 15(d) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”),
until the offering of the notes and the common shares covered by
this prospectus is completed; provided, however,
that we are not incorporating by reference any additional
documents or information furnished and not filed with the SEC:
•
Our Annual Report on
Form 10-K
for the year ended December 31, 2006.
•
Our Definitive Proxy Statement on Schedule 14A filed on
March 13, 2007.
•
The description of our common stock contained in our
Registration Statement on
Form 8-A,
filed under Section 12 of the Exchange Act, and all
amendments or reports filed for the purpose of updating that
description.
You may obtain copies of documents incorporated by reference in
this document, without charge, by writing us at the following
address or calling us at the telephone number listed below:
Orbital Sciences Corporation
21839 Atlantic Boulevard Dulles, Virginia20166
(703) 406-5000
Attention: General Counsel
Readers should rely on the information provided or incorporated
by reference in this prospectus or in any applicable supplement
to this prospectus. Readers should not assume that the
information in this prospectus and any applicable supplement is
accurate as of any date other than the date on the front cover
of the document.
The Private Securities Litigation Reform Act of 1995 provides a
safe harbor, in certain circumstances, for certain
forward-looking statements made by us or on our behalf. All
statements other than those of historical facts included or
incorporated by reference in this prospectus, including those
related to our financial outlook, liquidity, goals, business
strategy, projected plans and objectives of management for
future operating results, are
forward-looking
statements. These “forward-looking statements” involve
known and unknown risks and uncertainties that may cause our
actual results, performance or achievements to be materially
different from any future results, performance or achievements
expressed or implied by such forward-looking statements. The
forward-looking statements are and will be based on
management’s then-current views and assumptions regarding
future events and operating performance.
The following are some of the factors that could cause actual
results to differ materially from information contained in our
forward-looking statements:
•
our ability to satisfy future capital and operating requirements;
•
whether the U.S. government terminates or suspends our
contracts;
•
whether we are able to realize our backlog of orders, including
backlog we consider firm backlog;
•
whether there is continued U.S. government support and
funding for key space and defense programs;
•
whether our innovative products experience failures or
malfunctions;
•
our ability to timely fund and implement innovative and novel
technologies involving complex systems in a cost-effective
manner in the face of rapidly changing technology;
•
the establishment and expansion of commercial markets and
customer acceptance of our products;
•
the effects that competition may have on our ability to win new
contracts;
•
the outcome and potential effects on our business of the ongoing
U.S. government investigation which we believe is focused
on contracting matters related to certain U.S. government
launch vehicle programs;
•
the effect on our business of subsidization by foreign countries
of our foreign competitors or the imposition of other
protectionist measures; and
•
the other risks and uncertainties as are described below, and as
are described in our Annual Report on
Form 10-K
for the year ended December 31, 2006, and as may be
detailed from time to time in our public filings with the SEC.
Although we believe the expectations reflected in these
forward-looking statements are based on reasonable assumptions,
there is a risk that these expectations will not be attained and
that any deviations will be material. We disclaim any obligation
or undertaking to disseminate any updates or revisions to any
forward-looking statement contained in this prospectus to
reflect any changes in its expectations or any change in events,
conditions or circumstances on which any statement is based.
The following summary is qualified in its entirety by, and
should be read in conjunction with, the more detailed
information appearing elsewhere in this prospectus and the
documents incorporated by reference herein. Prospective
investors are urged to read this prospectus and the documents
incorporated by reference herein in their entirety. Unless the
context indicates otherwise, the terms “we,”“our,”“us,”“Orbital” and the
“Company” mean, collectively, Orbital Sciences
Corporation and its subsidiaries and their predecessors.
Our
Company
We develop and manufacture small rockets and space systems for
commercial, military and civil government customers, including
the U.S. Department of Defense (“DoD”), the
National Aeronautics and Space Administration (“NASA”)
and other U.S. government agencies. Our primary products
and services include the following:
•
Launch Vehicles. Rockets that are used as
interceptor and target vehicles for missile defense systems,
small-class space launch vehicles that place satellites into
Earth orbit, and suborbital launch vehicles that place payloads
into a variety of high-altitude trajectories.
•
Satellites and Space Systems. Earth-orbiting
satellites, interplanetary spacecraft and related systems for
communications, remote sensing, scientific and military
missions, satellite subsystems and space-related technical
services.
•
Transportation Management
Systems. Software-based transportation management
systems for public transit agencies and private vehicle fleet
operators.
Our general strategy is to develop and expand a core integrated
business of space and launch systems technologies and products,
focusing on the design and manufacturing of affordable
lightweight rockets, small satellites and other space systems in
order to establish and expand positions in niche markets that
have not typically been emphasized by our larger competitors.
Another part of our strategy is to seek customer contracts that
will fund the development of enhancements to our existing launch
vehicle and space systems product lines. As a result of our
capabilities and experience in designing, developing,
manufacturing and operating a broad range of small rockets and
space systems, we believe we are well positioned to capitalize
on the demand for small space-technology systems in missile
defense, space-based military and intelligence operations, and
commercial satellite communications programs, and to take
advantage of government-sponsored initiatives for space-based
scientific research and lunar and planetary exploration
initiatives.
Orbital was incorporated in Delaware in 1987 to consolidate the
assets, liabilities and operations of two entities established
in 1982 and 1983.
Our executive offices are located at 21839 Atlantic Boulevard,
Dulles, Virginia20166, and our telephone number is
(703) 406-5000.
Our Internet website is located at www.orbital.com.
Ratio of
Earnings to Fixed Charges
The following table sets forth our ratio of earnings to fixed
charges for each indicated period.
For the Years Ended December 31,
Pro Forma
2006
2005
2004
2003
2002
2006
Earnings to fixed charges
9.1
x
3.2
x
3.7
x
3.4
x
0.7
x
1.6x
For purposes of computing the ratio of earnings to fixed
charges, earnings include pre-tax income from continuing
operations and fixed charges. Earnings are also adjusted to
exclude allocated (gains) losses of equity investees. Fixed
charges consist of interest expense, debt extinguishment expense
and a portion of rental expense (deemed by management to be
representative of the interest factor of rental payments).
The pro forma calculation for 2006 is provided to show the
impact that the notes would have had if they had been issued
prior to January 1, 2006 rather than in December 2006,
using the proceeds of the issuance to extinguish all but
$0.5 million of our former 9% senior notes.
The
Notes
This summary is not a complete description of the notes. You
should read the full text and more specific details contained
elsewhere in this prospectus. For a more detailed description of
the notes, see the section entitled “Description of
Notes” in this prospectus. In this portion of the summary,
the terms “we,”“us,”“our” and
the “Company” refer to Orbital Sciences Corporation
and not to any of its subsidiaries.
Issuer
Orbital Sciences Corporation
Notes Offered
$143.75 million aggregate principal amount of 2.4375%
Convertible Senior Subordinated Notes due 2027.
Ranking of Notes
The notes are our unsecured, senior subordinated obligations.
The payment of the principal of and interest on the notes is
subordinated in right of payment to the prior payment in full in
cash of our existing and future senior indebtedness, including
obligations under our senior credit facility.
The notes also rank equally in express right of payment with our
existing and future senior subordinated indebtedness and senior
to any of our existing and future junior subordinated
indebtedness. The notes also rank effectively junior to our
secured indebtedness (including obligations under our amended
and restated credit agreement) to the extent of the underlying
collateral.
Interest
The notes bear interest at a rate of 2.4375% per year.
Interest is payable semi-annually in arrears on January 15 and
July 15 of each year, beginning July 15, 2007.
Maturity
The notes will mature on January 15, 2027 unless previously
redeemed, repurchased or converted in accordance with their
terms prior to such date.
Redemption of Notes at Our Option
Prior to January 21, 2014, we may not redeem the notes.
However, on or after January 21, 2014, we may redeem the
notes in whole or in part, upon not less than 30 nor more than
60 days’ prior written notice to holders of the notes,
for cash equal to 100% of the principal amount of the notes to
be redeemed plus any unpaid interest (including additional
interest, if any) accrued to the redemption date.
Repurchase of Notes at Each Holder’s Option on Certain Dates
Holders of notes may require us to repurchase their notes in
whole or in part on January 15, 2014, January 15, 2017
and January 15, 2022 for cash equal to 100% of the
principal amount of the notes to be repurchased plus any unpaid
interest (including additional interest, if any) accrued up to,
but excluding, the repurchase date.
Repurchase of Notes at Each Holder’s Option Upon
Fundamental Change
If at any time the Company undergoes a fundamental change,
holders of notes may require us to repurchase their notes in
whole or in part for cash equal to 100% of the principal amount
of the notes to be repurchased plus any unpaid interest
(including additional interest, if any) accrued to the
repurchase date.
Holders may surrender their notes for conversion for cash, or a
combination of cash and common shares, at our option, at the
applicable conversion rate, at any time on or after
January 15, 2026, but prior to the close of business on the
second business day immediately preceding the stated maturity
date, and also under any of the following circumstances:
• during any calendar quarter beginning after
March 31, 2007 (and only during such calendar quarter), if,
and only if, the closing sale price of our common shares for at
least 20 trading days (whether or not consecutive) in the period
of 30 consecutive trading days ending on the last trading day of
the preceding calendar quarter is greater than 130% of the
conversion price per common share in effect on the applicable
trading day;
• during the five consecutive
trading-day
period following any five consecutive
trading-day
period in which the trading price of the notes was less than 98%
of the product of the closing sale price of our common shares
multiplied by the applicable conversion rate;
• if the notes have been called for redemption, at any
time prior to the close of business on the third business day
prior to the redemption date; or
• upon the occurrence of specified transactions
described under “Description of Notes —
Conversion Rights” in this prospectus.
By delivering to the holder cash and common shares, if any, we
will satisfy our obligations with respect to the notes tendered
for conversion. Accordingly, upon conversion of a note, accrued
and unpaid interest will be deemed to be paid in full, rather
than cancelled, extinguished or forfeited.
Conversion Rate
The initial conversion rate for each $1,000 principal amount of
notes is 40.8513 common shares, payable in cash or, at our
election, common shares, as described under “Description of
Notes — Conversion Settlement” in this
prospectus. This is equivalent to an initial conversion price of
approximately $24.48 per common share. In addition, if
certain fundamental changes occur prior to January 21, 2014
and a holder elects to convert notes in connection with any such
transaction, we will increase the conversion rate in connection
with such conversion by a number of additional common shares
based on the date such transaction becomes effective and the
price paid per common share in such transaction as described
under “Description of Notes — Conversion
Rights — Make Whole Upon Fundamental Change” in
this prospectus. The conversion rate may also be adjusted under
certain other circumstances but will not be adjusted for accrued
and unpaid interest on the notes. See “Description of
Notes — Conversion Rate Adjustments” in this
prospectus.
Conversion Settlement
Upon conversion of notes we will deliver cash or, at our
election, a combination of cash and common shares, with an
aggregate value, which we refer to as the “conversion
value,” equal to the conversion rate multiplied by the
average price of common shares as
follows: (i) an amount in cash, which we refer to as the
“principal return,” equal to the lesser of
(a) the principal amount of the converted notes and
(b) the conversion value and (ii) if the conversion
value is greater than the principal return, an amount with a
value equal to the difference between the conversion value and
the principal return, which we refer to as the “net
amount.” The net amount may be paid, at our option, in
cash, common shares or a combination of cash and common shares.
We refer to any cash delivered upon a conversion of notes as
part of the net amount as the “net cash amount” and we
refer to any common shares delivered upon a conversion of notes
as the “net shares.” Any portion of the net amount we
elect to issue as net shares will be equal to the sum of the
daily share amounts (calculated as described under
“Description of Notes — Conversion
Settlement” in this prospectus) for each trading day in the
10 consecutive
trading-day
period referred to below, except that we will pay cash in lieu
of any fractional common shares issuable, at our option, as net
shares based on the average price of common shares.
The “average price” of common shares will be equal to
the average of the closing sale prices of common shares over the
10 consecutive
trading-day
period commencing on the third trading day following the date
the notes are tendered for conversion.
We will pay the principal return and cash for fractional shares,
and deliver net shares or pay the net cash amount, as
applicable, to holders upon a conversion of their notes no later
than the third business day following the last trading day of
the 10 consecutive
trading-day
period referred to above.
No Shareholder Rights for Holders of Notes
Holders of notes, as such, do not have any rights as
shareholders of the Company (including, without limitation,
voting rights and rights to receive dividends or other
distributions on our common shares).
Registration Rights
We have agreed to file with the SEC within 120 calendar days
after the original issuance of the notes, and to use our
reasonable best efforts to cause to become effective within 180
calendar days after the original issuance of the notes, this
shelf registration statement, or otherwise make a shelf
registration statement available, with respect to the resale of
the notes and the common shares that may be issuable upon
conversion of the notes. See “Description of
Notes — Registration Rights; Additional Interest”
in this prospectus.
If we fail to comply with specified obligations under the
registration rights agreement, additional interest will be
payable on the notes. See “Description of Notes —
Registration Rights; Additional Interest” in this
prospectus.
Trading
The notes are designated for trading on The
PORTALsm
Market. The notes sold using this prospectus, however, will no
longer be eligible for trading on The
PORTALsm
Market. We have not applied, and do not intend to apply, for the
listing of the notes on any securities exchange or for quotation
on any automated dealer
quotation system. Our common shares are listed on the New York
Stock Exchange under the symbol “ORB.”
Book-Entry Form
The notes are issued in book-entry form only and are represented
by one or more permanent global certificates deposited with a
custodian for, and registered in the name of a nominee of, The
Depository Trust Company, commonly known as DTC, in New York,
New York. Beneficial interests in a global certificate
representing the notes are shown on, and transfers will be
effected only through, records maintained by DTC and its direct
and indirect participants and such interests may not be
exchanged for certificated notes, except in limited
circumstances described in “Description of
Notes — Book-Entry System.”
Use of Proceeds
We will not receive any proceeds from the sale by any selling
securityholder of the notes or the common shares offered by this
prospectus.
Material Federal Income Tax Considerations
The notes and the common shares that may be issuable upon
conversion of the notes are subject to special and complex
U.S. federal income tax rules. Prospective investors are
strongly urged to consult their own tax advisors with respect to
the federal, state, local and foreign tax consequences of
purchasing, owning and disposing of the notes and the common
shares for which the notes, in certain circumstances, are
convertible. See “Material Federal Income Tax
Considerations” in this prospectus.
Risk Factors
You should read carefully the “Risk Factors” beginning
on page 6 of this prospectus, as well as the risk factors
relating to our business that are incorporated by reference in
this prospectus, for certain considerations relevant to an
investment in the notes and the common shares into which the
notes, in certain circumstances, are convertible.
You should carefully consider the risks described below, as
well as the risks described in the documents incorporated by
reference in this prospectus, before making a decision to invest
in the notes and common shares into which the notes, in certain
circumstances, are convertible. These risks are not the only
ones faced by us. Additional risks not presently known or that
are currently deemed immaterial could also materially and
adversely affect our financial condition, results of operations,
business and prospects. The trading price of the notes and
common shares into which the notes, under certain circumstances,
are convertible could decline due to any of these risks, and you
may lose all or part of your investment. This prospectus and the
documents incorporated herein by reference also contain
forward-looking statements that involve risks and uncertainties.
Actual results could differ materially from those anticipated in
these forward-looking statements as a result of certain factors,
including the risks faced by us described below and in the
documents incorporated herein by reference.
Risks
Related to the Notes and Common Stock
The
notes are unsecured and subordinated in right of payment to our
senior debt, including our senior credit facility, and
effectively subordinated in right of payment to our secured
indebtedness.
The notes are our unsecured, senior subordinated obligations.
The payment of the principal of, and interest on, the notes is
subordinated in right of payment to the prior payment in full in
cash of our existing and future senior indebtedness, including
obligations under our senior credit facility. The notes also
rank equally in express right of payment with our existing and
future senior subordinated indebtedness and senior to any of our
existing and future junior subordinated indebtedness. The notes
also rank effectively junior to our secured indebtedness
(including obligations under our senior credit facility) to the
extent of the underlying collateral.
As a result of such subordination, in the event of our
insolvency, bankruptcy, liquidation or reorganization or upon
acceleration of the notes due to an event of default under the
indenture and in certain other events, our secured lenders will
be entitled to exercise the remedies available to a secured
lender under applicable law and pursuant to instruments
governing such debt. Accordingly, such lenders will have a prior
claim on our assets. In that event, because the notes are not
secured by any of our assets, it is possible that there will be
no assets from which claims of holders of the notes can be
satisfied or, if any assets remain, the remaining assets might
be insufficient to satisfy those claims in full. As of
December 31, 2006, we had approximately $144 million
of outstanding senior and senior subordinated indebtedness
(including the notes) and no outstanding senior secured
indebtedness under our senior credit facility.
In addition, we will also be prohibited from making any payments
on the notes if any of our designated senior indebtedness is not
paid when due or has been declared due and payable because of a
default. In addition, in the event of certain other defaults in
respect of our designated senior indebtedness, we may be
prohibited from making payments on the notes. See
“Description of Notes — Subordination of the
Notes.”
Our senior credit facility contains covenants imposing financial
and operating restrictions on our business. These restrictions
may affect our ability to operate our business, may limit our
ability to take advantage of potential business opportunities as
they arise and may adversely affect the conduct of our current
business. These covenants place restrictions on our ability to,
among other things:
•
incur more debt;
•
pay dividends, redeem or repurchase our stock or make other
distributions;
Our
senior credit facility may restrict your ability to convert your
notes into cash
and/or
shares of our common stock or to cause us to repurchase the
notes.
Your ability to convert your notes into cash
and/or
shares of our common stock or to cause us to repurchase the
notes, if any, may be affected by the limitations imposed by our
current senior credit facility and by any limitations we may
have in any other credit facilities or indebtedness we may incur
in the future. Under our current senior credit facility, our
ability to pay any settlement amounts with respect to any
conversion of the notes, repurchase of the notes or redemption
of the notes will be restricted if there is an event of default
or if we are not in compliance with the financial covenants
under such senior credit facility.
We may
not have the cash necessary to pay the principal return and any
net amount upon a conversion of notes or to repurchase the notes
on specified dates or following certain fundamental change
transactions.
Upon a conversion of notes in accordance with their terms, we
will be required to pay the principal return of such notes in
cash. Furthermore, there may be circumstances that prevent the
issuance of shares of our common stock for all or any portion of
any net amount deliverable upon a conversion of notes, thereby
requiring us to satisfy our net amount obligation in cash.
Holders of notes also have the right to require us to repurchase
the notes for cash on January 15, 2014, January 15,2017 and January 15, 2022 or at any time upon the
occurrence of certain fundamental change transactions. Any of
our future debt agreements or securities may contain similar
provisions. We may not have sufficient funds to pay the
principal return and any such net cash amount or make the
required repurchase of notes, as the case may be, in cash at the
applicable time and, in such circumstances, may not be able to
arrange the necessary financing on favorable terms. In addition,
our ability to pay the principal return and any such net cash
amount or make the required repurchase, as the case may be, may
be limited by law or the terms of other debt agreements or
securities. However, our failure to pay the principal return and
any such net cash amount or make the required repurchase, as the
case may be, would constitute an event of default under the
indenture governing the notes which, in turn, could constitute
an event of default under other debt agreements or securities,
thereby resulting in their acceleration and required prepayment
and further restrict our ability to make such payments and
repurchases.
We
cannot assure you that an active trading market for the notes
will develop.
The notes are a new issue of securities for which there is
currently no established trading market. The notes are
designated for trading on The
PORTALsm
Market. However, notes sold pursuant to this prospectus will no
longer be eligible for trading on The
PORTALsm
Market. We do not intend to list the notes on any national
securities exchange or to seek the admission of the notes for
quotation on any automated quotation system. The absence of a
trading market may diminish the ability of the holders of the
notes to sell their notes or reduce the price at which the
holders would be able to sell their notes.
Our
stock price, and therefore the price of the notes, may fluctuate
significantly.
We expect that the market price of our notes will be
significantly affected by the market price of our common stock.
This may result in greater volatility in the trading value of
the notes than would be expected for
non-convertible
debt securities that we issue. Among the factors that could
affect our common stock price are those discussed in the risk
factors in the documents incorporated by reference in this
prospectus, as well as:
federal or state legislative, licensing or regulatory changes;
•
changes in revenue or earnings estimates or publication of
research reports by analysts;
•
speculation in the press or investment community;
•
strategic actions by us or our competitors;
•
general market conditions;
•
domestic and international factors unrelated to our performance;
•
future sales of our equity or equity linked securities; and
•
hedging or arbitrage trading.
In addition, we may purchase additional shares of our common
stock pursuant to our share repurchase program. These purchases
may raise or maintain the market price of our common stock above
independent market levels or prevent or retard a decline in the
market price of our common stock.
The
conditional conversion feature of the notes could result in your
not receiving the value of the common stock into which the notes
would otherwise be convertible.
The notes are convertible into cash and shares of our common
stock only if specific conditions are met. If the specific
conditions for conversion are not met, you will not be able to
convert your notes, and you may not be able to receive the value
of the common stock into which your notes would otherwise be
convertible. The contingent conversion feature could also
adversely affect the value of the trading prices of the notes.
The
notes are not protected by restrictive covenants.
The indenture governing the notes does not contain any financial
or operating covenants or restrictions on the payments of
dividends, the incurrence of indebtedness or the issuance or
repurchase of securities by us or any of our subsidiaries. The
indenture contains no covenants to afford protection to holders
of the notes in the event of a fundamental change involving us.
The
conversion rate of the notes may not be adjusted for all
dilutive events.
The conversion rate of the notes is subject to adjustment for
certain events, including, but not limited to, the issuance of
stock dividends on our common stock, the issuance of rights or
warrants, subdivisions, combinations, distributions of capital
stock, indebtedness or assets, certain cash dividends and
certain tender or exchange offers as described under
“Description of Notes — Conversion
Rights — Conversion Rate Adjustments.” The
conversion rate will not be adjusted for other events, such as
an issuance of common stock for cash, that may adversely affect
the trading price of the notes or the common stock. There can be
no assurance that an event that adversely affects the value of
the notes, but does not result in an adjustment to the
conversion rate, will not occur.
If we
adjust the conversion rate, you may have to pay taxes with
respect to amounts that you may not receive.
The conversion rate of the notes is subject to adjustment for
certain events arising from stock splits and combinations, stock
dividends, certain cash dividends and certain other actions by
us that modify our capital structure. See “Description of
Notes — Conversion Rights — Conversion Rate
Adjustments.” If the conversion rate is adjusted, you may
be required to include an amount in income for U.S. federal
income tax purposes, notwithstanding the fact that you may not
actually receive any distribution. If the conversion rate is
increased at our discretion or in certain other circumstances,
such increase also may be deemed to be the payment of a taxable
distribution to you, notwithstanding the fact that you may not
receive a cash payment. See “Material Federal Income Tax
Considerations — U.S. Holders —
Adjustment of Conversion Price.”
Conversion
of the notes may dilute the ownership interest of existing
stockholders, including holders who had previously converted
their notes.
Upon conversion of the notes, we will deliver cash equal to the
lesser of the aggregate principal amount of the notes to be
converted and their conversion value, and common stock or cash
in respect of the excess, if any, of conversion value over
principal return. If we issue common stock upon conversion of
the notes, the conversion of some or all of the notes will
dilute the ownership interests of existing stockholders. Any
sales in the public market of the common stock issuable upon
such conversion could adversely affect prevailing market prices
of our common stock. In addition, the existence of the notes may
encourage short selling by market participants because the
conversion of the notes could depress the price of our common
stock.
If you
hold notes, you will not be entitled to any rights with respect
to our common stock, but you will be subject to all changes made
with respect to our common stock.
If you hold notes, you will not be entitled to any rights with
respect to our common stock (including, without limitation,
voting rights and rights to receive any dividends or other
distributions on our common stock), but you will be subject to
all changes affecting the common stock. You will have rights
with respect to our common stock only if, when and to the extent
we deliver shares of common stock to you upon conversion of your
notes and, in limited cases, under the conversion rate
adjustments applicable to the notes. For example, in the event
that an amendment is proposed to our articles of incorporation
or by-laws requiring stockholder approval and the record date
for determining the stockholders of record entitled to vote on
the amendment occurs prior to delivery of common stock to you,
you will not be entitled to vote on the amendment, although you
will nevertheless be subject to any changes in the powers,
preferences or special rights of our common stock.
The
additional shares of common stock payable on notes converted in
connection with certain fundamental change transactions may not
adequately compensate you for any lost option time value of your
notes as a result of such fundamental change
transactions.
If certain fundamental change transactions occur at any time
after the date of issuance of the notes, we will increase the
conversion rate on notes converted in connection with such
fundamental change transaction by a number of additional shares
of our common stock. The number of such additional shares of
common stock will be determined based on the date on which the
fundamental change transaction becomes effective and the price
paid per share of our common stock in the fundamental change
transaction as described below under “Description of
Notes — Conversion Rights — Conversion upon
Specified Transactions.” While the increase in the
conversion rate upon conversion is designed to compensate you
for any lost option time value of your notes as a result of such
fundamental change transactions, such increase is only an
approximation of such lost value and may not adequately
compensate you for such loss. In addition, if the price paid per
share of our common stock in the fundamental change transaction
is less than the common stock price at the date of issuance,
there will be no such increase in the conversion rate.
The
repurchase rights in the notes triggered by a fundamental change
could discourage a potential acquirer.
The repurchase rights in the notes triggered by a fundamental
change, as described under the heading “Description of
Notes — Repurchase at Option of the Holder Upon a
Fundamental Change,” could discourage a potential acquirer.
The term “fundamental change” is limited to specified
transactions and may not include other events that might
adversely affect our financial condition or business operations.
Our obligation to offer to repurchase the notes upon a
fundamental change would not necessarily afford you protection
in the event of a highly leveraged transaction, reorganization,
merger or similar transaction involving us.
Upon
conversion of the notes, you may receive fewer proceeds than
expected because the value of our common stock may decline
between the day that you exercise your conversion right and the
day the conversion value of your notes is
determined.
The conversion value that you will receive upon conversion of
your notes is determined by the average of the closing price of
our common stock for ten consecutive trading days beginning on
the third trading day immediately following the day you deliver
your conversion notice to the conversion agent. If the price of
our common stock decreases after we receive your notice of
conversion and prior to the end of the applicable ten trading
day period, the conversion value you receive will be adversely
affected.
We
have never paid any cash dividends on our common
stock.
We have never paid any cash dividends on our common stock and do
not intend to declare any cash dividends on our common stock in
the foreseeable future. Because the notes are convertible into
shares of our common stock, these factors may also affect the
value of the notes.
Our
restated certificate of incorporation, our amended and restated
bylaws, our stockholder rights plan and Delaware law contain
anti-takeover provisions that may adversely affect the rights of
our stockholders.
Our Board of Directors has the authority to issue up to
10 million shares of our preferred stock, $0.01 par
value per share, and to determine the price, rights, preferences
and privileges of those shares without any further vote or
action by the stockholders. The rights of the holders of our
common stock will be subject to, and may be adversely affected
by, the rights of the holders of any preferred stock that may be
issued in the future. The issuance of preferred stock, while
providing desirable flexibility in connection with possible
acquisitions and other corporate purposes, could have the effect
of making it more difficult for a third party to acquire a
majority of our outstanding voting stock.
In addition to our ability to issue preferred stock without
stockholder approval, our charter documents contain other
provisions which could have an anti-takeover effect, including:
•
our charter provides for a staggered Board of Directors as a
result of which only one of the three classes of directors is
elected each year;
•
any merger, acquisition or other business combination that is
not approved by our Board of Directors must be approved by
662/3%
of voting stockholders;
•
stockholders holding less than 10% of our outstanding voting
stock cannot call a special meeting of stockholders; and
•
stockholders must give advance notice to nominate directors or
submit proposals for consideration at stockholder meetings.
In 1998, we adopted a stockholder rights plan which is intended
to deter coercive or unfair takeover tactics. Under the rights
plan, a preferred share purchase right, which is attached to
each share of our common stock, generally will be triggered upon
the acquisition, or actions that would result in the
acquisition, of 15% or more of our common stock by any person or
group. If triggered, these rights would entitle our stockholders
(other than the acquirer) to purchase, for the exercise price,
shares of Orbital’s common stock having a market value of
two times the exercise price. The exercise price, which is
subject to certain adjustments, is $210 per right. The
stock purchase rights would cause substantial dilution to a
person or group that attempts to acquire us on terms not
approved by our Board of Directors.
In addition, we are subject to the anti-takeover provisions of
Section 203 of the Delaware General Corporation Law, which
restrict the ability of current stockholders holding more than
15% of our voting shares to acquire us without the approval of
662/3%
of the other stockholders. These provisions could discourage
potential acquisition proposals and could delay or prevent a
change in control transaction. They could also have the effect
of discouraging others from making tender offers for our common
stock. As a result, these provisions may prevent our stock price
from increasing substantially in response to actual or rumored
takeover attempts. These provisions may also prevent changes in
our management.
We develop and manufacture small rockets and space systems for
commercial, military and civil government customers, including
DoD, NASA and other U.S. government agencies.
Our primary products and services include the following:
•
Launch Vehicles. Rockets that are used as
interceptor and target vehicles for missile defense systems,
small-class space launch vehicles that place satellites into
Earth orbit, and suborbital launch vehicles that place payloads
into a variety of high-altitude trajectories.
•
Satellites and Space Systems. Earth-orbiting
satellites, interplanetary spacecraft and related systems for
communications, remote sensing, scientific and military
missions, satellite subsystems and space-related technical
services.
•
Transportation Management
Systems. Software-based transportation management
systems for public transit agencies and private vehicle fleet
operators.
Our general strategy is to develop and expand a core integrated
business of space and launch systems technologies and products,
focusing on the design and manufacturing of affordable
lightweight rockets, small satellites and other space systems in
order to establish and expand positions in niche markets that
have not typically been emphasized by our larger competitors.
Another part of our strategy is to seek customer contracts that
will fund the development of enhancements to our existing launch
vehicle and space systems product lines. As a result of our
capabilities and experience in designing, developing,
manufacturing and operating a broad range of small rockets and
space systems, we believe we are well positioned to capitalize
on the demand for small space-technology systems in missile
defense, space-based military and intelligence operations, and
commercial satellite communications programs, and to take
advantage of government-sponsored initiatives for space-based
scientific research and lunar and planetary exploration
initiatives.
Orbital was incorporated in Delaware in 1987 to consolidate the
assets, liabilities and operations of two entities established
in 1982 and 1983.
Our executive offices are located at 21839 Atlantic Boulevard,
Dulles, Virginia20166 and our telephone number is
(703) 406-5000.
Employees
As of February 26, 2007, we employed approximately 2,800
permanent employees. None of our employees is subject to
collective bargaining agreements. We believe our employee
relations are good.
As of March 23, 2007, there were 2,300 stockholders of
record of our common stock.
Our common stock trades on the New York Stock Exchange
(“NYSE”) under the symbol “ORB.” The range
of high and low sales prices of Orbital common stock, as
reported on the NYSE, was as follows:
We have never paid any cash dividends on our common stock, nor
do we anticipate paying cash dividends on our common stock at
any time in the foreseeable future. Moreover, our amended and
restated credit agreement contains covenants limiting our
ability to pay cash dividends.
The following description summarizes certain terms and
provisions of the notes, the indenture and the registration
rights agreement that we entered into, does not purport to be
complete and is subject to, and qualified in its entirety by
reference to, the actual terms and provisions of the notes, the
indenture and the registration rights agreement, each of which
we have previously filed with the SEC and which are incorporated
herein by reference. We will provide copies of these documents
to you upon request.
Capitalized terms used but not otherwise defined herein shall
have the meanings given to them in the notes, the indenture or
the registration rights agreement, as applicable. As used in
this section, the terms “we,”“us,”“our” or the “Company” refer to Orbital
Sciences Corporation and not to any of its subsidiaries. Unless
the context otherwise requires, the term “interest”
includes additional interest, if any, due under the registration
rights agreement.
General
The notes were issued pursuant to an indenture, dated as of
December 13, 2006, between the Company and The Bank of New
York, as trustee. We refer to the indenture, as amended,
supplemented or modified from time to time, as the
“indenture.”
The terms of the notes include those provisions contained in the
notes and the indenture and those made part of the indenture by
reference to the Trust Indenture Act of 1939, as amended
(the “Trust Indenture Act”). The notes are subject to
all such terms, and holders of notes are referred to the notes,
the indenture and the Trust Indenture Act for a statement
thereof. Copies of the indenture and the form of the notes are
available for inspection at the corporate trust office of the
trustee, currently located at 101 Barclay Street — 8W,
New York, New York10286.
The notes are our unsecured, senior subordinated obligations.
The payment of the principal of and interest on the notes will
be subordinated in right of payment to the prior payment in full
in cash of our existing and future senior indebtedness,
including obligations under our senior credit facility, as
described under “— Subordination of the
Notes” below. The notes also rank equally in express right
of payment with our future senior subordinated indebtedness and
senior to any of our existing and future junior subordinated
indebtedness. The notes also rank effectively junior to our
secured indebtedness (including obligations under our senior
credit facility) to the extent of the underlying collateral. As
of December 31, 2006 we had approximately $144 million
of outstanding senior and senior subordinated indebtedness
(including the notes) and no senior secured indebtedness under
our senior credit facility.
The notes are limited to the aggregate principal amount of
$143,750,000.
The notes are issued only in fully registered, book-entry form,
in denominations of $1,000 and integral multiples thereof,
except under the limited circumstances described below under
“— Book-Entry System” in this prospectus.
Holders may convert notes at the office of the conversion agent,
present notes for registration of transfer at the office of the
registrar for the notes and present notes for payment at
maturity at the office of the paying agent. We have appointed
the trustee as the initial conversion agent, registrar and
paying agent for the notes.
If any interest payment date, stated maturity date, redemption
date or repurchase date is not a business day, the payment
otherwise required to be made on such date will be made on the
next business day without any additional payment as a result of
such delay. The term “business day” means, with
respect to any note, any day, other than a Saturday, Sunday or
any other day on which banking institutions in The City of New
York are authorized or obligated by law or executive order to
close. All payments will be made in U.S. dollars.
The terms of the notes provide that we are permitted to reduce
interest payments and payments upon a redemption, repurchase or
conversion of notes otherwise payable to a holder for any
amounts we are required to withhold by law. For example,
non-U.S. holders
of notes may, under some circumstances, be subject to
U.S. federal withholding tax with respect to payments of
interest on the notes. Moreover, holders of convertible debt
instruments such as the notes may, in certain circumstances, be
deemed to have received
distributions of stock if the conversion price of such
instruments is adjusted even though such holders have not
received any cash or property as a result of such adjustments,
which deemed distribution (in the case of a
non-U.S. holder)
will be subject to a U.S. federal withholding tax. See
“Material Federal Income Tax Considerations” in this
prospectus. We will set-off any such withholding tax that we are
required to pay against payments of interest payable on the
notes and payments upon a redemption, repurchase or conversion
of notes.
The indenture does not contain any provisions that would protect
holders of notes if we were involved in a highly leveraged
transaction, reorganization, merger or other similar transaction
that may adversely affect us or them. Furthermore, the notes
contain certain features that could deter or discourage third
party acquisition proposals that could be beneficial to holders.
We are not subject to any financial covenants under the
indenture. In addition, the indenture does not restrict our
ability to pay distributions, incur debt or issue or repurchase
our securities.
We or one of our affiliates may, to the extent permitted by
applicable law, at any time purchase notes in the open market,
by tender at any price or by private agreement. Any note
purchased by us or our affiliates (a) after the date that
is two years from the latest issuance of the notes may, to the
extent permitted by applicable law, be reissued or sold or may
be surrendered to the trustee for cancellation or (b) on or
prior to the date referred to in clause (a), will be surrendered
to the trustee for cancellation. Any notes surrendered for
cancellation may not be reissued or resold and will be canceled
promptly.
Interest
Interest on the notes accrues at the rate of 2.4375% per
year from and including December 13, 2006 or the most
recent interest payment date to which interest has been paid or
provided for, and is payable semi-annually in arrears on January
15 and July 15 of each year, beginning July 15, 2007. The
interest so payable will be paid to each holder in whose name a
note is registered at the close of business on the January 1 or
July 1 (whether or not a business day) immediately
preceding the applicable interest payment date. Interest on the
notes is computed on the basis of a
360-day year
consisting of twelve
30-day
months. In addition, we may be required to pay additional
interest on the notes as provided below under
“— Registration Rights; Additional Interest”
below.
Upon conversion of notes, accrued interest thereon will be
deemed to be paid by delivery of the consideration due to the
converting holder upon such conversion, except that holders of
notes on a record date will be entitled to receive interest
payable on the related interest payment date even if such notes
are converted after such record date and on or prior to such
interest payment date. However, unless (i) we have called
the notes for redemption or (ii) if we have scheduled a
fundamental change repurchase date, on a redemption date or
fundamental change repurchase date, as the case may be, that
falls after a record date for an interest payment date and on or
prior to the related interest payment date, holders who
surrender their notes for conversion after such record date and
on or prior to such interest payment date must pay to the
conversion agent upon conversion an amount in cash equal to the
interest payable by us on such interest payment date. The
foregoing sentence shall not, however, apply to notes with
overdue interest or additional interest due and owing at the
time of the conversion, with respect to such overdue interest or
additional interest, as applicable. No other payment or
adjustment will be made for accrued interest on a converted note.
If we redeem the notes, or if a holder surrenders a note for
repurchase by us in accordance with the terms of such note, we
will pay accrued and unpaid interest (including additional
interest, if any) to the holder that surrenders such note for
redemption or repurchase, as the case may be. However, if an
interest payment date falls on or prior to the redemption date
or repurchase date for a note, we will pay the accrued and
unpaid interest (including additional interest, if any) due on
that interest payment date instead to the record holder of such
note at the close of business on the related record date.
The notes will mature on January 15, 2027 and will be paid
against presentation and surrender thereof at the corporate
trust office of the trustee unless (1) earlier redeemed by
us at our option or repurchased by us at a holder’s option
at certain times as described under “— Our
Redemption Rights,”“— Repurchase at
Option of Holders on Certain Dates” or
“— Repurchase at Option of Holders Upon
Fundamental Change” below or (2) converted at a
holder’s option as permitted under
“— Conversion Rights” below. The notes are
not entitled to the benefits of, or subject to, any sinking fund.
Our
Redemption Rights
We do not have the right to redeem any notes prior to
January 21, 2014. On or after January 21, 2014, we
have the right to redeem the notes in whole or in part, at any
time or from time to time, for cash equal to 100% of the
principal amount of the notes to be redeemed plus unpaid
interest (including additional interest, if any) accrued to the
redemption date. If the redemption date is after the close of
business on the record date for the payment of an installment of
interest and before the related interest payment date, then the
payment of interest becoming due on that date will be payable to
the holder of record at the close of business on the relevant
record date, and the redemption price will not include such
interest payment. Written notice of redemption must be delivered
to holders of the notes not less than 30 nor more than
60 days prior to the redemption date.
If the paying agent holds money sufficient to pay the redemption
price due on a note on the redemption date in accordance with
the terms of the indenture, then, on and after the redemption
date, that note will cease to be outstanding and interest on
that note will cease to accrue, whether or not the holder
effects a book-entry transfer of that note or delivers that note
to the paying agent. Thereafter, all other rights of the holder
of that note terminate, other than the right to receive the
redemption price and additional interest, if any, due on the
redemption date.
If we decide to redeem the notes in part, the trustee will
select the notes to be redeemed (in principal amounts of $1,000
and integral multiples thereof) on a pro rata basis or such
other method it deems fair and appropriate. If the trustee
selects a portion of a note for partial redemption and a holder
converts a portion of the same note, the converted portion will
be deemed to be from the portion selected for redemption.
In the event of any redemption of notes in part, we will not be
required to:
•
issue or register the transfer or conversion of any note during
a period beginning at the opening of business 15 days
before any selection of notes for redemption and ending at the
close of business on the earliest date on which the relevant
notice of redemption is deemed to have been given to all holders
of notes to be so redeemed, or
•
register the transfer or conversion of any note so selected for
redemption, in whole or in part, except the unredeemed portion
of any note being redeemed in part.
If we call notes for redemption, a holder may convert its notes
only until the close of business on the third business day
immediately preceding the redemption date, unless we fail to pay
the redemption price. See “Conversion Rights —
Conversion upon Notice of Redemption” below.
Repurchase
at Option of Holders on Certain Dates
Holders of notes may require us to repurchase their notes in
whole or in part (in principal amounts of $1,000 and integral
multiples thereof) on January 15, 2014, January 15,2017 and January 15, 2022 for cash equal to 100% of the
principal amount of the notes to be repurchased plus unpaid
interest (including additional interest, if any) accrued to the
repurchase date. To exercise its repurchase right, a holder must
deliver a written repurchase notice to the paying agent, which
initially is the trustee, during the period beginning at any
time from the opening of business on the date that is
30 days prior to the repurchase date until the close of
business on the third business day prior to the repurchase date.
Our repurchase obligation will be subject to certain additional
conditions.
On or before the 30th day prior to each repurchase date, we
will provide to the trustee, any paying agent and to all holders
of the notes, and to beneficial owners as required by applicable
law, a notice stating, among other things:
•
the repurchase price;
•
the name and address of the trustee and any paying agent;
•
that notes with respect to which the holder has delivered a
repurchase notice may be converted, if otherwise convertible,
only if the holder withdraws the repurchase notice in accordance
with the terms of the indenture; and
•
the procedures that holders must follow to require us to
repurchase their notes.
We will also disseminate a press release through Dow
Jones & Company, Inc. or Bloomberg Business News
containing the information specified in such notice or publish
that information in a newspaper of general circulation in The
City of New York or on our web site, or through such other
public medium as we deem appropriate at that time.
A holder’s notice electing to require us to repurchase
notes must specify:
•
if such notes are in certificated form, the certificate
number(s) of the notes to be repurchased;
•
the principal amount of notes to be repurchased, in integral
multiples of $1,000; and
•
that the notes are to be repurchased by us pursuant to the
applicable provisions of the indenture and the notes.
Holders may withdraw any repurchase notice in whole or in part
by a written notice of withdrawal delivered to the paying agent
prior to the close of business on the third business day prior
to the repurchase date. If a holder of notes delivers a
repurchase notice, it may not thereafter surrender such notes
for conversion unless such repurchase notice is withdrawn as
permitted below. The notice of withdrawal must specify:
•
the name of the holder;
•
the principal amount of notes in respect of which the repurchase
notice is being withdrawn, which must be an integral multiple of
$1,000;
•
if the notes subject to the withdrawal notice are in
certificated form, the certificate number(s) of all notes
subject to the withdrawal notice; and
•
the principal amount of notes, if any, that remains subject to
the repurchase notice, which must be an integral multiple of
$1,000.
If the notes are in book-entry form, the above notices must also
comply with the appropriate procedures of The Depository Trust
Company, or “DTC.”
Holders electing to require us to repurchase notes must either
effect book-entry transfer of notes in book-entry form in
compliance with appropriate DTC procedures or deliver the notes
in certificated form, together with necessary endorsements, to
the paying agent prior to the repurchase date to receive payment
of the repurchase price on the repurchase date. We will pay the
repurchase price within two business days after the later of the
repurchase date or the time of such transfer or delivery of the
notes.
If the paying agent holds funds sufficient to pay the repurchase
price of the notes on the repurchase date, then on and after
such date:
•
such notes will cease to be outstanding;
•
interest on such notes will cease to accrue; and
•
all rights of holders of such notes will terminate except the
right to receive the repurchase price.
Such will be the case whether or not book-entry transfer of the
notes in book-entry form is made and whether or not notes in
certificated form, together with the necessary endorsements, are
delivered to the paying agent.
No notes may be repurchased by us at the option of the holders
thereof if there has occurred and is continuing an event of
default with respect to the notes (other than a default in the
payment of the repurchase price for those notes). In addition,
we may also be unable to repurchase the notes in accordance with
their terms, and we may be subject to contractual restrictions
that limit our ability to repurchase the notes. See “Risk
Factors — We may not have the cash necessary to pay
the principal return and any net amount upon a conversion of
notes or to repurchase the notes on specified dates or following
a fundamental change” in this prospectus.
To the extent legally required in connection with a repurchase
of notes, we will comply with the provisions of
Rule 13e-4
and other tender offer rules under the Exchange Act then
applicable, if any, and will file a Schedule TO or any
other schedule required under the Exchange Act.
We may arrange for a third party to purchase any notes for which
we receive a valid repurchase notice that is not withdrawn, in
the manner and otherwise in compliance with the requirements set
forth in the terms of the notes applicable to the repurchase
right with respect to the notes. If a third party purchases any
notes under these circumstances, then interest will continue to
accrue on those notes and those notes will continue to be
outstanding after the repurchase date and will be fungible with
all other notes then outstanding. The third party subsequently
may resell those purchased notes to other investors.
Repurchase
at Option of Holders Upon a Fundamental Change
If a fundamental change occurs at any time, holders of notes may
require us to repurchase their notes in whole or in part for
cash equal to 100% of the principal amount of the notes to be
repurchased plus unpaid interest (including additional interest,
if any) accrued to the repurchase date. If such repurchase date
is after a record date but prior to an interest payment date,
however, then the interest payable on such date will be paid to
the holder of record of the notes on the relevant record date.
Within 20 days after the occurrence of a fundamental
change, we are obligated to give to the holders of the notes
notice of the fundamental change and of the repurchase right
arising as a result of the fundamental change and the repurchase
date (which may be no earlier than 15 days and no later
than 30 days after the date of such notice). We must also
deliver a copy of this notice to the trustee. We will also
disseminate a press release through Dow Jones &
Company, Inc. or Bloomberg Business News announcing the
occurrence of the fundamental change or publish that information
in a newspaper of general circulation in The City of New York,
or on our web site, or through such other public medium as we
deem appropriate at that time.
To exercise its repurchase right, a holder of notes must deliver
to the trustee prior to the close of business on the third
business day prior to the repurchase date written notice of such
holder’s exercise of its repurchase right. Such notice must
state:
•
if such notes are in certificated form, the certificate
number(s) of the notes to be repurchased;
•
the portion of the principal amount of notes to be repurchased,
in multiples of $1,000; and
•
that the notes are to be repurchased by us pursuant to the
applicable provisions of the notes.
Holders may withdraw any repurchase notice in whole or in part
by a written notice of withdrawal delivered to the paying agent
prior to the close of business on the third business day prior
to the repurchase date. If a holder of notes delivers a
repurchase notice, it may not thereafter surrender such notes
for conversion unless such repurchase notice is withdrawn as
permitted below. The notice of withdrawal must specify:
•
the name of the holder;
•
the principal amount of notes in respect of which the repurchase
notice is being withdrawn, which must be an integral multiple of
$1,000;
if the notes subject to the withdrawal notice are in
certificated form, the certificate number(s) of all notes
subject to the withdrawal notice; and
•
the principal amount of notes, if any, that remains subject to
the repurchase notice, which must be an integral multiple of
$1,000.
If the notes are in book-entry form, the above notices must
comply with the appropriate procedures of DTC.
Holders electing to require us to repurchase notes must either
effect book-entry transfer of notes in book-entry form in
compliance with appropriate DTC procedures or deliver the notes
in certificated form, together with necessary endorsements, to
the paying agent prior to the repurchase date to receive payment
of the repurchase price on the repurchase date. We will pay the
repurchase price within two business days after the later of the
repurchase date or the time of such transfer or delivery of the
notes.
If the paying agent holds funds sufficient to pay the repurchase
price of the notes on the repurchase date, then on and after
such date:
•
such notes will cease to be outstanding;
•
interest on such notes will cease to accrue; and
•
all rights of holders of such notes will terminate except the
right to receive the repurchase price.
Such will be the case whether or not book-entry transfer of the
notes in book-entry form is made and whether or not notes in
certificated form, together with the necessary endorsements, are
delivered to the paying agent.
A “fundamental change” will be deemed to have occurred
at the time that any of the following occurs:
•
consummation of any transaction or event (whether by means of a
share exchange or tender offer applicable to the Company’s
common shares, a liquidation, consolidation, recapitalization,
reclassification, combination or merger of the Company or a
sale, lease or other transfer of all or substantially all of the
consolidated assets of the Company) or a series of related
transactions or events pursuant to which all of the outstanding
common shares of the Company are exchanged for, converted into
or constitute solely the right to receive cash, securities or
other property;
•
any “person” or “group” (as such terms are
used for purposes of Sections 13(d) and 14(d) of the
Exchange Act, whether or not applicable), other than any
majority-owned subsidiary of the Company or any employee benefit
plan of the Company or such subsidiary, is or becomes the
“beneficial owner,” directly or indirectly, of more
than 50% of the total voting power in the aggregate of all
classes of shares of beneficial interest of the Company then
outstanding entitled to vote generally in elections of directors;
•
during any period of 12 consecutive months after the date of
original issuance of the notes, persons who at the beginning of
such 12 month period constituted the board of directors of
the Company, together with any new persons whose election was
approved by a vote of a majority of the persons then still
comprising the board of directors who were either members of the
board of directors at the beginning of such period or whose
election, designation or nomination for election was previously
so approved, cease for any reason to constitute a majority of
the board of directors of the Company;
•
our common stock (or other common stock into which the notes are
then convertible) ceases to be listed on a national securities
exchange or on the Nasdaq Market, The Nasdaq Capital Market or
quoted on an established automated
over-the-counter
trading market in the United States; or
•
our stockholders approve any plan or proposal for the
liquidation or dissolution of the Company.
However, even if any of the events specified in the first three
bullet points above have occurred, except as indicated below, a
“fundamental change” will not be deemed to have
occurred if either:
(A) the closing sale price of the Company’s common
shares for any five trading days within (1) the period of
10 consecutive trading days ending immediately after the later
of the fundamental change or the public announcement of the
fundamental change, in the case of a fundamental change relating
to an acquisition of capital stock, or (2) the period of 10
consecutive trading days ending immediately after the
fundamental change, in the case of a fundamental change relating
to a merger, consolidation or asset sale, equals or exceeds 105%
of the conversion price applicable to the notes on each of those
trading days; provided, however, that the exception to
the definition of “fundamental change” specified in
this clause (A) shall not apply in the context of a
“change of control” as described under
“— Conversion Rights — Conversion Upon
Specified Transactions” or “— Conversion
Rights — Make Whole Upon Fundamental Change”
below; or
(B) at least 90% of the consideration (excluding cash
payments for fractional shares and cash payments made pursuant
to dissenters’ appraisal rights) in a merger, consolidation
or other transaction otherwise constituting a fundamental change
consists of shares of common stock (or depositary receipts or
other certificates representing common equity interests) traded
on a national securities exchange or quoted on the Nasdaq Market
or another established automated
over-the-counter
trading market in the United States (or will be so traded or
quoted immediately following such merger, consolidation or other
transaction) and as a result of the merger, consolidation or
other transaction the notes become convertible into such shares
of common stock (or depositary receipts or other certificates
representing common equity interests).
For purposes of these provisions “person” includes any
syndicate or group that would be deemed to be a
“person” under Section 13(d)(3) of the Exchange
Act.
The definition of “fundamental change” includes a
phrase relating to the sale, lease or other transfer of
“all or substantially all” of the consolidated assets
of the Company. There is no precise, established definition of
the phrase “substantially all” under applicable law.
Accordingly, the ability of a holder of notes to require us to
repurchase its notes as a result of the sale, lease or other
transfer of less than all of the consolidated assets of the
Company may be uncertain.
No notes may be repurchased by us at the option of the holders
thereof if there has occurred and is continuing an event of
default with respect to the notes (other than a default in the
payment of the repurchase price for those notes). In addition,
we may also be unable to repurchase the notes in accordance with
their terms. See “Risk Factors — We may not have
the cash necessary to pay the principal return and any net
amount upon a conversion of notes or to repurchase the notes on
specified dates or following certain fundamental change
transactions” in this prospectus.
To the extent legally required in connection with a repurchase
of notes, we will comply with the provisions of
Rule 13e-4
and other tender offer rules under the Exchange Act then
applicable, if any, and will file a Schedule TO or any
other required schedule under the Exchange Act.
We may arrange for a third party to purchase any notes for which
we receive a valid repurchase notice that is not withdrawn, in
the manner and otherwise in compliance with the requirements set
forth in the terms of the notes applicable to the repurchase
right with respect to the notes. If a third party purchases any
notes under these circumstances, then interest will continue to
accrue on those notes and those notes will continue to be
outstanding after the repurchase date and will be fungible with
all other notes then outstanding. The third party subsequently
may resell those purchased notes to other investors.
Holders of notes, as such, will not have any rights as
shareholders of the Company (including, without limitation,
voting rights and rights to receive any dividends or other
distributions on the Company’s common shares).
Conversion
Rights
Subject to the conditions described below, holders may convert
their notes for cash or a combination of cash and common shares,
at our option, initially at a conversion rate of 40.8513 common
shares per $1,000 principal amount of notes (equivalent to an
initial conversion price of approximately $24.48 per common
share). The conversion rate and the equivalent conversion price
in effect at any given time are referred to in this prospectus
as the “conversion rate” and the “conversion
price,” respectively, and will be subject to adjustment as
described herein.
Upon conversion of a note, a holder will not receive any cash
payment of interest (unless such conversion occurs after a
record date and on or prior to the interest payment date to
which it relates) and we will not adjust the conversion rate to
account for accrued and unpaid interest. Our delivery to the
holder of cash and, if applicable, common shares, if any, will
be deemed to satisfy our obligation with respect to notes
tendered for conversion. Accordingly, upon conversion of notes,
any accrued but unpaid interest will be deemed to be paid in
full, rather than cancelled, extinguished or forfeited.
Holders of notes at the close of business on a record date for
an interest payment will receive payment of interest payable on
the corresponding interest payment date notwithstanding the
conversion of such notes at any time after the close of business
on the applicable regular record date. Notes tendered for
conversion by a holder after the close of business on any record
date for an interest payment and on or prior to the
corresponding interest payment date must be accompanied by
payment of an amount equal to the interest that the holder is to
receive on the notes; provided, however, that no such
payment will be required to be made (1) if we have
specified a redemption date that is after such record date and
on or prior to such interest payment date, (2) if we have
scheduled a fundamental change repurchase date that is after
such record date and on or prior to such interest payment date,
or (3) with respect to overdue interest (including
additional interest), if any overdue interest is due or owing at
the time of conversion with respect to such notes.
If a holder converts notes and we elect to deliver common
shares, we will pay any documentary, stamp or similar issue or
transfer tax due on the issue of common shares upon conversion,
if any, unless the tax is due because the holder requests the
shares to be issued or delivered to a person other than the
holder, in which case the holder will pay that tax prior to
receipt of such common shares.
If a holder wishes to exercise its conversion right, such holder
must deliver an irrevocable duly completed and manually signed
conversion notice, together, if the notes are in certificated
form, with the certificated security, to the conversion agent
along with appropriate endorsements and transfer documents, if
required or, if the notes are in book-entry form, comply with
appropriate procedures of DTC, and pay any transfer or similar
tax, if required. The conversion agent will, on the
holder’s behalf, convert the notes into cash and common
shares, if any. Holders may obtain copies of the required form
of the conversion notice from the conversion agent.
If a holder has already delivered a repurchase notice as
described under either “— Repurchase at Option of
Holders on Certain Dates” or “— Repurchase
at Option of Holders upon a Fundamental Change” above, with
respect to a note, that holder may not tender that note for
conversion until the holder has properly withdrawn the
repurchase notice.
Upon surrender of a note for conversion, the holder shall
deliver to us cash equal to the amount that we are required to
deduct and withhold under applicable law in connection with such
conversion; provided, however, that if the holder does
not deliver such cash, we may deduct and withhold from the
consideration otherwise deliverable to such holder the amount
required to be deducted and withheld under applicable law.
Holders may surrender their notes for conversion for cash, or a
combination of cash and common stock, at our option, at the
applicable conversion rate, at any time on or after
January 15, 2026, but prior to the close of business on the
second business day immediately preceding the stated maturity
date, and also under any of the following circumstances:
•
during any calendar quarter beginning after March 31, 2007
(and only during such calendar quarter) if, and only if, the
closing sale price of the Company’s common shares for at
least 20 trading days (whether or not consecutive) in the period
of 30 consecutive trading days ending on the last trading day of
the preceding calendar quarter is more than 130% of the
conversion price per common share in effect on the applicable
trading day;
•
during the five consecutive
trading-day
period following any five consecutive
trading-day
period in which the trading price of the notes was less than 98%
of the product of the closing sale price of the Company’s
common shares multiplied by the applicable conversion rate;
•
if those notes have been called for redemption, at any time
prior to the close of business on the third business day prior
to the redemption date; or
•
during prescribed periods upon the occurrence of specified
transactions discussed below.
“Closing sale price” of the Company’s
common shares or other capital stock or similar equity interests
or other publicly traded securities on any date means the
closing sale price per share (or, if no closing sale price is
reported, the average of the closing bid and ask prices or, if
more than one in either case, the average of the average closing
bid and the average closing ask prices) on such date as reported
on the principal United States securities exchange on which the
Company’s common shares or such other capital stock or
similar equity interests or other securities are traded or, if
the Company’s common shares or such other capital stock or
similar equity interests or other securities are not listed on a
United States national or regional securities exchange, as
reported by the Nasdaq Market or by the National Quotation
Bureau Incorporated or another established
over-the-counter
trading market in the United States. The closing sale price will
be determined without regard to
after-hours
trading or extended market making. In the absence of the
foregoing, we will determine the closing sale price on such
basis as we consider appropriate.
“Trading day” means a day during which trading
in securities generally occurs on the NYSE or, if the
Company’s common shares are not then listed on the NYSE, on
the principal other United States national or regional
securities exchange on which the Company’s common shares
are then listed or, if the Company’s common shares are not
then listed on a United States national or regional securities
exchange, on the Nasdaq Market or, if our common shares are not
then quoted on the Nasdaq Market, in the principal other market
on which our common shares are then traded.
Conversion
upon Satisfaction of Market Price Condition
A holder may surrender any of its notes for conversion during
any calendar quarter beginning after March 31, 2007 (and
only during such calendar quarter) if, and only if, the closing
sale price of our common shares for at least 20 trading days
(whether or not consecutive) in the period of 30 consecutive
trading days ending on the last trading day of the preceding
calendar quarter is more than 130% of the conversion price per
common share in effect on the applicable trading day. Our board
of directors will make appropriate adjustments, in its good
faith determination, to account for any adjustment to the
conversion rate that becomes effective, or any event requiring
an adjustment to the conversion rate where the ex-dividend date
of the event occurs, during that 30 consecutive
trading-day
period.
Conversion
upon Satisfaction of Trading Price Condition
A holder may surrender any of its notes for conversion during
the five consecutive
trading-day
period following any five consecutive
trading-day
period in which the trading price per $1,000 principal amount of
notes (as determined following a reasonable request by a holder
of the notes) was less than 98% of the product of the closing
sale price of our common shares multiplied by the applicable
conversion rate.
The “trading price” of the notes on any date of
determination means the average of the secondary market bid
quotations per $1,000 principal amount of notes obtained by the
trustee for a $2.0 million principal amount of notes at
approximately 3:30 p.m., New York City time, on such
determination date from two independent nationally recognized
securities dealers we select, which may include the initial
purchasers; provided that if at least two such bids cannot
reasonably be obtained by the trustee, but one such bid can
reasonably be obtained by the trustee, then one bid shall be
used. If the trustee cannot reasonably obtain at least one bid
for a $2.0 million principal amount of notes from a
nationally recognized securities dealer or, in our reasonable
judgment, the bid quotations are not indicative of the secondary
market value of the notes, then the trading price per $1,000
principal amount of notes will be deemed to be less than 98% of
the product of the closing sale price of our common shares and
the applicable conversion rate on such determination date.
The trustee shall have no obligation to determine the trading
price of the notes unless we have requested such determination,
and we shall have no obligation to make such request unless a
holder provides us with reasonable evidence that the trading
price per $1,000 principal amount of notes would be less than
98% of the product of the closing sale price of our common
shares and the applicable conversion rate, whereupon we shall
instruct the trustee to determine the trading price of the notes
beginning on the next trading day and on each successive trading
day until the trading price is greater than or equal to 98% of
the product of the closing sale price of our common shares and
the applicable conversion rate.
Conversion
upon Notice of Redemption
A holder may surrender for conversion any of the notes called
for redemption at any time prior to the close of business on the
third business day prior to the redemption date, even if the
notes are not otherwise convertible at such time. The right to
convert notes will expire at that time, unless we default in
making the payment due upon redemption. A holder may convert
fewer than all of its notes so long as the notes converted are
an integral multiple of $1,000 principal amount. However, if a
holder has already delivered a repurchase notice with respect to
a note, such holder may not surrender that note for conversion
until it has withdrawn such notice in accordance with the terms
of the notes.
distribute to all holders of our common shares certain rights
entitling them to purchase, for a period expiring within
60 days, our common shares at less than the average of the
closing sale prices of our common shares for the 10 consecutive
trading days immediately preceding the declaration date of such
distribution; or
•
distribute to all holders of our common shares assets, debt
securities or certain rights to purchase securities of the
Company, which distribution has a per share value exceeding 10%
of the closing sale price of our common shares on the trading
day immediately preceding the declaration date of such
distribution,
we must notify the holders of notes at least 20 days prior
to the ex-dividend date for such distribution. Once we have
given that notice, holders may surrender their notes for
conversion at any time until the earlier of the close of
business on the business day prior to the ex-dividend date or an
announcement that such distribution will not take place;
provided, however, that a holder may not exercise this
right to convert if the holder may participate, on an
as-converted basis, in the distribution without conversion of
the notes. The ex-dividend date is the first date upon which a
sale of our common shares does not automatically transfer the
right to receive the relevant distribution from the seller of
our common shares to its buyer.
In addition, if the Company is a party to a consolidation,
merger or binding share exchange pursuant to which all of its
common shares would be converted for cash, securities or other
property that is not otherwise a fundamental change, a holder
may surrender its notes for conversion at any time from and
including the date that is 15 business days prior to the
anticipated effective time of the transaction up to and
including five business days after the actual date of such
transaction. We will notify holders as promptly as practicable
following the date we publicly announce such transaction (but in
no event less than 15 business days prior to the anticipated
effective time of such transaction).
If a fundamental change occurs as a result of a transaction
described in the first, second, third or fourth bullets of the
definition of fundamental change, a holder will have the right
to convert its notes at any time from and including the day that
is 15 business days prior to the anticipated effective date of
such transaction up to and including the trading day prior to
the fundamental change repurchase date, subject to expiration of
a holder’s conversion right with respect to any notes
submitted for repurchase. We will notify holders as promptly as
practicable following the date we publicly announce such
fundamental change (but in no event later than 15 business days
prior to the effective date of such fundamental change).
If the Company is a party to a consolidation, merger or binding
share exchange pursuant to which all of its common shares are
exchanged for cash, securities or other property, then at the
effective time of the transaction any conversion of notes and
the conversion value will be based on the kind and amount of
cash, securities or other property that a holder of notes would
have received if such holder had converted its notes for the
Company’s common shares immediately prior to the effective
time of the transaction. For purposes of the foregoing, where a
consolidation, merger or binding share exchange involves a
transaction that causes our common shares to be converted into
the right to receive more than a single type of consideration
based upon any form of stockholder election, such consideration
will be deemed to be the weighted average of the types and
amounts of consideration received by the holders of our common
shares that affirmatively make such an election. If a
fundamental change occurs prior to January 21, 2014, we
will adjust the conversion rate for notes tendered for exchange
in connection with the transaction, as described below under
“— Conversion Rights — Make Whole Upon
Fundamental Change.”
Conversion
Settlement
Upon conversion of notes, we will deliver, in respect of each
$1,000 principal amount of notes tendered for conversion in
accordance with their terms:
•
cash in an amount (the “principal return”) equal to
the lesser of (a) the principal amount of notes surrendered
for conversion and (b) the conversion value, and
•
if the conversion value is greater than the principal return, an
amount (the “net amount”) in cash or our common
shares, at our option, with an aggregate value equal to the
difference between the conversion value and the principal return
as described in this prospectus.
We may elect to deliver any portion of the net amount in cash
(which we refer to as the “net cash amount”) or our
common shares, and any portion of the net amount we elect to
deliver in our common shares (the “net shares”) will
be the sum of the daily share amounts (calculated as described
below) for each trading day during the applicable conversion
period. Prior to the close of business on the second trading day
following the date on which notes are tendered for conversion,
we will inform holders of such notes of our election to pay cash
for all or a portion of the net amount and, if applicable, the
portion of the net amount that will be paid in cash and the
portion that will be delivered in the form of net shares.
We will deliver cash in lieu of any fractional common shares
issuable in connection with payment of the net shares based upon
the average price.
The “conversion value” for each $1,000 principal
amount of notes is equal to (a) the applicable conversion
rate, multiplied by (b) the average price.
The “applicable conversion period” means the 10
consecutive
trading-day
period commencing on the third trading day following the date
the notes are tendered for conversion.
The “average price” is equal to the average of the
closing sale prices of our common shares for each trading day in
the applicable conversion period.
The “daily share amount” for each $1,000 principal
amount of notes and each trading day in the applicable
conversion period is equal to the greater of:
•
zero; and
•
a number of our common shares determined by the following
formula:
(closing sale price of our common
shares on such trading day × applicable conversion
rate)−($1,000 + net cash amount, if any)
10 × closing sale price of
our common shares on such trading day
The conversion value, principal return, net amount, net cash
amount and the number of net shares, as applicable, will be
determined by us promptly after the end of the applicable
conversion period. We will pay the principal return and cash in
lieu of fractional shares, and deliver net shares or pay the net
cash amount, as applicable, no later than the third business day
following the last trading day of the applicable conversion
period.
Conversion
Rate Adjustments
The conversion rate shall be adjusted from time to time as
follows:
(i) If the Company issues common shares as a dividend or
distribution on its common shares to all holders of its common
shares, or if the Company effects a share split or share
combination, the conversion rate will be adjusted based on the
following formula:
CR1 =
CR0
×
OS1/OS0
where
CR0 =
the conversion rate in effect immediately prior to the
adjustment relating to such event
CR1 =
the new conversion rate in effect taking such event into account
OS0 =
the number of our common shares outstanding immediately prior to
such event
OS1 =
the number of our common shares outstanding immediately after
such event.
Any adjustment made pursuant to this
paragraph (i) shall become effective on the date that
is immediately after (x) the date fixed for the
determination of shareholders entitled to receive such dividend
or other distribution or (y) the date on which such split
or combination becomes effective, as applicable. If any dividend
or distribution described in this paragraph (i) is
declared but not so paid or made, the new conversion rate shall
be readjusted to the conversion rate that would then be in
effect if such dividend or distribution had not been declared.
(ii) If the Company issues to all holders of its common
shares any rights, warrants, options or other securities
entitling them for a period of not more than 60 days after
the date of issuance thereof to subscribe for or purchase its
common shares, or issues to all holders of its common shares
securities convertible into its common shares for a period of
not more than 60 days after the date of issuance thereof,
in either case at an exercise price per common share or a
conversion price per common share less than the closing sale
price of its common shares on the business day immediately
preceding the time of announcement of such issuance, the
conversion rate will be adjusted based on the following formula:
CR1 =
CR0
×
(OS0+X)/(OS0+Y)
where
CR0 =
the conversion rate in effect immediately prior to the
adjustment relating to such event
CR1 =
the new conversion rate taking such event into account
OS0 =
the number of common shares outstanding immediately prior to
such event
the total number of common shares issuable pursuant to such
rights, warrants, options, other securities or convertible
securities
Y =
the number of common shares equal to the quotient of
(A) the aggregate price payable to exercise such rights,
warrants, options, other securities or convertible securities
divided by (B) the average of the closing sale prices of
common shares for the 10 consecutive trading days prior to the
business day immediately preceding the date of announcement for
the issuance such rights, warrants, options, other securities or
convertible securities.
For purposes of this paragraph (ii), in determining whether
any rights, warrants, options, other securities or convertible
securities entitle the holders to subscribe for or purchase, or
exercise a conversion right for, common shares at less than the
applicable closing sale price of our common shares, and in
determining the aggregate exercise or conversion price payable
for such common shares, there shall be taken into account any
consideration received by the Company for such rights, warrants,
options, other securities or convertible securities and any
amount payable on exercise or conversion thereof, with the value
of such consideration, if other than cash, to be determined by
the Company’s board of directors. If any right, warrant,
option, other security or convertible security described in this
paragraph (ii) is not exercised or converted prior to
the expiration of the exercisability or convertibility thereof,
the new conversion rate shall be readjusted to the conversion
rate that would then be in effect if such right, warrant,
option, other security or convertible security had not been so
issued.
(iii) If the Company distributes shares of capital stock,
evidences of indebtedness or other assets or property of the
Company to all holders of its common shares, excluding:
(A) dividends, distributions, rights, warrants, options,
other securities or convertible securities referred to in
paragraph (i) or (ii) above,
(B) dividends or distributions paid exclusively in
cash, and
(C) Spin-Offs described below in this paragraph (iii),
then the conversion rate will be adjusted based on the following
formula:
CR1 = CR0
×
SP0/(SP0−FMV)
where
CR0 = the
conversion rate in effect immediately prior to the adjustment
relating to such event
CR1 = the
new conversion rate taking such event into account
SP0 =
the average of the closing sale prices of common shares for the
10 consecutive trading days prior to the business day
immediately preceding the earlier of the record date or the
ex-dividend date for such distribution
FMV =
the fair market value (as determined in good faith by the
Company’s board of directors) of the shares of capital
stock, evidences of indebtedness, assets or property distributed
with respect to each outstanding common share on the earlier of
the record date or the ex-dividend date for such distribution.
An adjustment to the conversion rate made pursuant to the
immediately preceding paragraph shall be made successively
whenever any such distribution is made and shall become
effective on the day immediately after the date fixed for the
determination of holders of common shares entitled to receive
such distribution.
If the Company distributes to all holders of its common shares
capital stock of any class or series, or similar equity
interest, of or relating to a subsidiary or other business unit
of the Company (a “Spin-Off”), the conversion rate in
effect immediately before the close of business on the date
fixed for
determination of holders of common shares entitled to receive
such distribution will be adjusted based on the following
formula:
CR1 =
CR0
×
(FMV0+MP0)/MP0
where
CR0 =
the conversion rate in effect immediately prior to the
adjustment relating to such event
CR1 =
the new conversion rate taking such event into account
FMV0 =
the average of the closing sale prices of the capital stock or
similar equity interest distributed to holders of the common
shares applicable to one common share over the first 10
consecutive trading days after the effective date of the Spin-Off
MP0 =
the average of the closing sale prices of the common shares over
the first 10 consecutive trading days after the effective date
of the Spin-Off.
An adjustment to the conversion rate made pursuant to the
immediately preceding paragraph will occur on the
10th trading day after the effective date of the Spin-Off.
If any such dividend or distribution described in this
paragraph (iii) is declared but not paid or made, the
new conversion rate shall be readjusted to be the conversion
rate that would then be in effect if such dividend or
distribution had not been declared.
(iv) If the Company makes any cash dividend or distribution
to all holders of its common shares in respect of any of its
quarterly fiscal periods (without regard to when paid), the
conversion rate will be adjusted based on the following formula:
CR1 =
CR0
×
SP0/(SP0−C)
where
CR0 =
the conversion rate in effect immediately prior to the
adjustment relating to such event
CR1 =
the new conversion rate taking such event into account
SP0 =
the average of the closing sale prices of the common shares for
the 10 consecutive trading days prior to the business day
immediately preceding the earlier of the record date or the day
prior to the ex-dividend date for such distribution
C =
the amount in cash per share that the Company distributes to
holders of its common shares in respect of such quarterly fiscal
period.
An adjustment to the conversion rate made pursuant to this
paragraph (iv) shall become effective on the date
immediately after the date fixed for the determination of
holders of common shares entitled to receive such dividend or
distribution. If any dividend or distribution described in this
paragraph (iv) is declared but not so paid or made,
the new conversion rate shall be readjusted to the conversion
rate that would then be in effect if such dividend or
distribution had not been declared.
(v) If the Company or any of its subsidiaries makes a
payment in respect of a tender offer or exchange offer for its
common shares to the extent that the cash and value of any other
consideration included in the payment per common share exceeds
the closing sale price of a common share on the trading day next
succeeding the last date on which tenders or exchanges may be
made pursuant to such tender or exchange offer (the
“Expiration Time”), the conversion rate will be
adjusted based on the following formula:
CR1 =
CR0
× (AC +
(SP1
×OS1))/(SP1
×
OS0)
where
CR0 =
the conversion rate in effect immediately prior to the
adjustment relating to such event
the new conversion rate taking such event into account
AC =
the aggregate value of all cash and any other consideration (as
determined by the Company’s board of directors) paid or
payable for the common shares purchased in such tender or
exchange offer
OS0 =
the number of common shares outstanding immediately prior to the
date such tender or exchange offer expires
OS1 =
the number of common shares outstanding immediately after such
tender or exchange offer expires (after giving effect to the
purchase or exchange of shares pursuant to such tender or
exchange offer)
SP1 =
the average of the closing sale prices of the common shares for
the 10 consecutive trading days commencing on the trading day
next succeeding the date such tender or exchange offer expires.
If the application of the foregoing formula would result in a
decrease in the conversion rate, no adjustment to the conversion
rate will be made.
Any adjustment to the conversion rate made pursuant to this
paragraph (v) shall become effective on the date
immediately following the Expiration Time. If the Company or one
of its subsidiaries is obligated to purchase the Company’s
common shares pursuant to any such tender or exchange offer but
is permanently prevented by applicable law from effecting any
such purchase or all such purchases are rescinded, the new
conversion rate shall be readjusted to be the conversion rate
that would be in effect if such tender or exchange offer had not
been made.
(vi) Notwithstanding the foregoing, in the event of an
adjustment to the conversion rate pursuant to
paragraphs (iv) or (v), in no event will the
conversion rate exceed 53.1067, subject to adjustment pursuant
to paragraphs (i), (ii) and (iii).
(vii) If the Company has in effect a rights plan while any
notes remain outstanding, holders of notes will receive, upon
conversion of notes in respect of which we have elected to
deliver net shares, in addition to such net shares, rights under
the Company’s shareholder rights agreement unless, prior to
conversion, the rights have expired, terminated or been redeemed
or unless the rights have separated from the common shares. If
the rights provided for in the rights plan adopted by the
Company have separated from the common shares in accordance with
the provisions of the applicable shareholder rights agreement so
that holders of notes would not be entitled to receive any
rights in respect of common shares that we elect to deliver as
net shares upon conversion of notes, the conversion rate will be
adjusted at the time of separation as if the Company had
distributed to all holders of common shares capital stock,
evidences of indebtedness or other assets or property pursuant
to paragraph (iii) above, subject to readjustment upon
the subsequent expiration, termination or redemption of the
rights. In lieu of any such adjustment, the Company may amend
such applicable shareholder rights agreement to provide that
upon conversion of notes the holders will receive, in addition
to common shares that we elect to deliver as net shares upon
such conversion, the rights which would have attached to such
common shares if the rights had not become separated from the
common shares under such applicable shareholder rights
agreement. To the extent that the Company adopts any future
shareholder rights agreement, upon a conversion of notes in
respect of which we elect to deliver common shares as net
shares, a holder of notes shall receive, in addition to common
shares, the rights under the future shareholder rights agreement
whether or not the rights have separated from the common shares
at the time of conversion and no adjustment will be made in
accordance with paragraph (iii) or otherwise.
In addition to the adjustments pursuant to
paragraphs (i) through (vii) above, we may
increase the conversion rate in order to avoid or diminish any
income tax to holders of our common shares resulting from any
dividend or distribution of capital stock (or rights to acquire
common shares) or from any event treated as such for income tax
purposes. We may also, from time to time, to the extent
permitted by applicable law, increase the conversion rate by any
amount for any period if we have determined that such increase
would be
in the best interests of the Company. If we make such
determination, it will be conclusive and we will mail to holders
of the notes a notice of the increased conversion rate and the
period during which it will be in effect at least 15 days
prior to the date the increased conversion rate takes effect in
accordance with applicable law.
We will not make any adjustment to the conversion rate if
holders of the notes are permitted to participate, on an
as-converted basis, in the transactions described above.
The applicable conversion rate will not be adjusted upon certain
events, including but not limited to:
•
the issuance of any common shares pursuant to any present or
future plan providing for the reinvestment of dividends or
interest payable on securities of the Company and the investment
of additional optional amounts in shares of our common shares
under any plan;
•
the issuance of any common shares or options or rights to
purchase those shares pursuant to any present or future
employee, director or consultant benefit plan, employee
agreement or arrangement or program of the Company;
•
the issuance of any common shares pursuant to any option,
warrant, right, or exercisable, exchangeable or convertible
security outstanding as of the date the notes were first issued;
•
a change in the par value of our common shares; and
•
accumulated and unpaid dividends or distributions.
No adjustment in the conversion price will be required unless
the adjustment would require an increase or decrease of at least
1% of the conversion price. If the adjustment is not made
because the adjustment does not change the conversion price by
at least 1%, then the adjustment that is not made will be
carried forward and taken into account in any future adjustment.
All required calculations will be made to the nearest cent or
1/1000th of a share, as the case may be. Notwithstanding
the foregoing, if the notes are called for redemption, upon a
fundamental change or upon a conversion by a holder, all
adjustments not previously made will be made on the applicable
redemption date.
If certain of the possible adjustments to the conversion price
of the notes are made, a holder may be deemed to have received a
distribution from the Company or additional interest from us
even though such holder has not received any cash or property as
a result of such adjustments. We intend to withhold federal
income tax (in the case of a
non-U.S. holder)
with respect to any deemed distribution from the Company, from
cash payments of interest and payments in redemption, repurchase
or conversion of the notes. See “Material Federal Income
Tax Considerations” in this prospectus.
Make
Whole Upon Fundamental Change
If a fundamental change occurs as a result of a transaction
described in the first, second, third or fourth bullets of the
definition of fundamental change (as set forth above under
“— Repurchase at Option of Holders upon a
Fundamental Change”) prior to January 21, 2014 and a
holder elects to convert its notes in connection with such
fundamental change as described above under
“— Conversion Rights — Conversion upon
Specified Transactions,” we will increase the applicable
conversion rate for the notes surrendered for conversion by a
number of additional common shares (the “additional
fundamental change shares”) as described below. A
conversion of notes will be deemed for these purposes to be
“in connection with” such a fundamental change if the
notice of conversion of the notes is received by the conversion
agent from and including the day that is 15 business days prior
to the anticipated effective date of the fundamental change up
to and including the trading day prior to the fundamental change
repurchase date.
The number of additional fundamental change shares will be
determined by reference to the table below and is based on the
date on which such fundamental change transaction becomes
effective (the “effective date”) and the price (the
“stock price”) paid per common share in such
transaction. If the holders of common shares receive only cash
in the fundamental change transaction, the stock price shall be
the cash amount paid per common share. Otherwise, the stock
price shall be the average of the closing sale prices of our
common shares on the 10 consecutive trading days up to but
excluding the effective date.
The stock prices set forth in the first row of the table
(i.e., the column headers) will be adjusted as of any
date on which the conversion rate of the notes is adjusted. The
adjusted stock prices will equal the stock prices applicable
immediately prior to such adjustment multiplied by a fraction,
the numerator of which is the conversion rate immediately prior
to the adjustment giving rise to the stock price adjustment and
the denominator of which is the conversion rate as so adjusted.
In addition, the number of additional fundamental change shares
will be subject to adjustment in the same manner as the
conversion rate as set forth above under
“— Conversion Rate Adjustments.”
The following table sets forth the stock price and number of
additional fundamental change shares of the Company to be
received per $1,000 principal amount of notes:
Effective date
$18.83
$20.00
$22.50
$25.00
$27.50
$30.00
$35.00
$40.00
$45.00
$50.00
$55.00
$60.00
$65.00
$70.00
$75.00
12/8/2006
12.26
10.88
8.61
6.98
5.78
4.86
3.60
2.79
2.23
1.83
1.52
1.29
1.10
0.94
0.82
1/15/2008
12.26
10.72
8.35
6.66
5.44
4.52
3.28
2.51
1.99
1.62
1.35
1.14
0.97
0.84
0.72
1/15/2009
12.26
10.50
8.01
6.27
5.03
4.11
2.91
2.19
1.72
1.39
1.15
0.97
0.83
0.72
0.62
1/15/2010
12.26
10.28
7.64
5.82
4.54
3.63
2.47
1.81
1.40
1.13
0.93
0.79
0.68
0.58
0.51
1/15/2011
12.26
10.02
7.17
5.25
3.94
3.04
1.95
1.37
1.04
0.83
0.69
0.58
0.50
0.44
0.38
1/15/2012
12.26
9.75
6.61
4.51
3.17
2.28
1.31
0.86
0.63
0.50
0.42
0.36
0.31
0.27
0.24
1/15/2013
12.26
9.35
5.76
3.50
2.10
1.28
0.52
0.29
0.20
0.17
0.14
0.12
0.11
0.10
0.09
1/21/2014
12.26
9.15
4.56
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
The exact stock prices and effective dates may not be set forth
in the table, in which case:
(1) if the stock price is between two stock price amounts
in the table or the effective date is between two dates in the
table, the additional fundamental change shares will be
determined by straight-line interpolation between the number of
additional fundamental change shares set forth for the higher
and lower stock price amounts and the two dates, as applicable,
based on a
365-day year;
(2) if the stock price is in excess of $75.00 per
common share (subject to adjustment), no additional fundamental
change shares will be issued upon conversion; and
(3) if the stock price is less than $18.83 per common
share (subject to adjustment), no additional fundamental change
shares will be issued upon conversion.
Notwithstanding the foregoing, in no event will the total number
of common shares issuable upon conversion exceed
53.1067 per $1,000 principal amount of notes, subject to
adjustment in the same manner as the conversion rate as set
forth above under “— Conversion Rate
Adjustments.”
Calculations
in Respect of the Notes
Except as explicitly specified otherwise herein, we will be
responsible for making all calculations required under the
notes. These calculations include, but are not limited to,
determinations of the conversion price and conversion rate
applicable to the notes. We will make all these calculations in
good faith and, absent manifest error, our calculations will be
final and binding on holders of the notes. We will provide a
schedule of our calculations to the trustee, and the trustee is
entitled to rely upon the accuracy of our calculations without
independent verification. The trustee will forward our
calculations to any holder of notes upon request within 20
business days of the effective date of any adjustment.
Subordination
of the Notes
The notes, and all other payment obligations (including
additional interest under the registration rights agreement)
with respect thereto, are our unsecured obligations and are
subordinated in right of payment to the prior payment in full in
cash or other payment satisfactory to holders of indebtedness of
all obligations under our amended and restated credit agreement
and all of our other existing and future senior indebtedness.
The notes are pari passu in right of payment to all of our other
senior subordinated indebtedness and senior in right of payment
to all of our junior subordinated indebtedness. As of
December 31, 2006, we had approximately
$144 million of outstanding senior and senior subordinated
indebtedness (including the notes) and no outstanding senior
secured indebtedness under our amended and restated credit
agreement.
Only our senior indebtedness ranks senior in right of payment to
the notes pursuant to the provisions of the indenture. The notes
in all respects have the same rank in right of payment as any of
our future senior subordinated indebtedness and rank senior in
right of payment to any of our junior subordinated indebtedness.
Such senior indebtedness continues to be senior indebtedness and
be entitled to the benefits of the subordination provisions
irrespective of any amendment, modification or waiver of any
term of such senior indebtedness, including, without limitation,
any modifications to interest rates or fees or dates of payment
of interest, fees or principal or to financial or other
covenants or events of default, as well as any release of any
collateral or person obligated on such senior indebtedness, or
other waiver or forbearance. By reason of such subordination, in
the event of dissolution, insolvency, bankruptcy, receivership,
liquidation, reorganization or other similar proceedings, or
upon any winding up, liquidation or dissolution, in each case
whether voluntary or involuntary, or any assignment for the
benefit of our creditors or any other marshalling of our assets
and liabilities, upon any payment or distribution of our assets
or securities,
•
holders of senior indebtedness will be entitled to receive
payment in full in cash or other payment satisfactory to the
holder of all obligations before the holders of notes or any of
our other senior subordinated indebtedness will be entitled to
receive any payment of principal, premium, paid in cash, if any,
or interest on the notes, or payment upon a redemption,
conversion, repurchase at the option of the holder or repurchase
upon a fundamental change at the option of the holder of the
notes;
•
the holders of the notes are required to hold in trust and pay
over their share of such payment or distribution to the holders
of senior indebtedness or their representative for application
to the payment of all senior indebtedness remaining unpaid, to
the extent necessary to pay all holders of senior indebtedness
in full in cash or other payment satisfactory to the holders of
senior indebtedness; and
•
holders of senior indebtedness may recover more, ratably, and
holders of the notes may recover less, ratably, than our other
creditors.
In addition, no payment of the principal amount, redemption
price, cash portion of the conversion value, repurchase price,
or interest or other cash obligations with respect to any notes
may be made by us, nor may we redeem or acquire any notes, if:
•
any payment default on any designated senior indebtedness has
occurred and is continuing; or
•
any default (other than a payment default) with respect to
designated senior indebtedness occurs and is continuing that
permits the acceleration of the maturity thereof and the trustee
receives a written notice that blocks payment under the notes (a
“payment blockage notice”) from (a) the
administrative agent for the lenders under our amended and
restated credit agreement or (b) the holders of any other
designated senior indebtedness or their representatives.
Notwithstanding the foregoing, payments with respect to the
notes may resume and we may redeem or acquire notes for cash
when:
•
in the case of a payment default with respect to the designated
senior indebtedness, the date upon which such payment default is
cured or waived in writing or ceases to exist; or
•
in the case of a non-payment default described in the second
bullet above, the earliest of (x) the date on which such
non-payment default is cured, waived in writing or ceases to
exist (so long as no other default exists),
(y) 179 days after the applicable payment blockage
notice is received or (z) the date on which the trustee
receives notice from a representative of designated senior
indebtedness rescinding such payment blockage notice, unless, in
each case, the maturity of any designated senior indebtedness
has been accelerated, provided that the terms of the indenture
otherwise permit the payment, redemption or acquisition of the
notes at that time.
No new payment blockage notice may be delivered in connection
with a non-payment default unless and until:
•
360 days have elapsed since the delivery of the immediately
prior payment blockage notice; and
•
all scheduled payments of principal, interest and additional
amounts, if any, on the notes that have come due have been paid
in full in cash.
No nonpayment default that existed or was continuing on the date
of delivery of any payment blockage notice to the trustee will
be, or be made, the basis for a subsequent payment blockage
notice unless such default has been cured or waived in writing
for a period of not less than 90 days. Upon any payment or
distribution of our assets or securities to creditors upon any
dissolution, winding up, liquidation or reorganization of us,
whether voluntary or involuntary, or in bankruptcy, insolvency,
receivership or other similar proceedings, the holders of all
senior indebtedness shall first be entitled to receive payment
in full, in cash or other payment satisfactory to the holders of
senior indebtedness, of all obligations due or to become due in
respect of such senior indebtedness before the holders of the
notes shall be entitled to receive any payment or distribution
with respect to any notes.
If the trustee or any holder of the notes receives a payment in
respect of the notes when the payment is prohibited by these
subordination provisions, the trustee or the holder, as the case
may be, will hold the payment in trust for the benefit of the
holders of senior indebtedness. Upon the proper written request
of the holders of senior indebtedness, the trustee or the
holder, as the case may be, will deliver the amounts in trust to
the holders of the senior indebtedness or their proper
representative which, with respect to any and all indebtedness
under the amended and restated credit agreement, shall mean the
agent for such holders.
The Company must properly notify holders of the senior
indebtedness if payment of the notes is accelerated because of
an event of default.
No provision contained in the indenture or the notes affects our
obligation, which is absolute and unconditional, to pay the
notes when due. The subordination provisions of the indenture
will not prevent the occurrence of any default or event of
default under the indenture. The subordination provisions shall
not be amended or modified without the written consent of the
holders of at least 75% in aggregate principal amount of the
notes then-outstanding if such amendment would adversely affect
the rights of the holders of the notes.
No
Layering of Indebtedness
We will not incur, create, issue, assume, guarantee or otherwise
become liable for any indebtedness that is subordinate or junior
in right of payment to any of senior indebtedness and senior in
right of payment to the notes.
Other than as set forth in the preceding paragraph, the
indenture does not limit the amount of additional indebtedness,
including senior or secured indebtedness, which we can create,
incur, assume or guarantee, nor does the indenture limit the
amount of Indebtedness or other liabilities that our
subsidiaries can create, incur, assume or guarantee.
Merger,
Consolidation or Sale
We may consolidate with, or sell, lease or convey all or
substantially all of its assets to, or merge with or into, any
other corporation, limited liability company, association,
partnership, real estate investment trust, company or business
trust, provided that:
•
the Company is the continuing entity, or the successor entity or
its transferees or assignees of such assets (if other than the
Company) formed by or resulting from any such consolidation or
merger or which shall have received the transfer of such assets
by sale, lease or conveyance, shall, either directly or
indirectly, expressly assume payment of the principal of, and
interest on, the notes and the due and punctual performance and
observance of all of the covenants contained in the indenture,
subject to the Company’s continuing obligations set forth
in the indenture, or otherwise;
if as a result of such transaction the notes become convertible
into common stock or other securities issued by a third party,
such third party assumes or fully and unconditionally guarantees
all obligations under the notes and the indenture;
•
the successor entity formed by or resulting from any such
consolidation or merger or which shall have received the
transfer of assets shall be a United States entity;
•
immediately after giving effect to such transaction, no event of
default under the indenture, and no event which, after notice or
the lapse of time, or both, would become such an event of
default, shall have occurred and be continuing; and
•
an officer’s certificate of the Company and legal opinion
covering such conditions shall be delivered to the trustee.
Events of
Default, Notice and Waiver
The following events are “events of default” with
respect to the notes:
•
default by us for 30 days in the payment of any installment
of interest (including additional interest, if any) on the notes
whether or not provided by the subordination provisions of the
indenture;
•
default by us in the payment of the principal of the notes when
the same becomes due and payable, whether on the stated maturity
date or any earlier date of redemption or repurchase or
otherwise whether or not provided by the subordination
provisions of the indenture;
•
default in the delivery when due of the conversion value, on the
terms set forth in the indenture and the notes, upon exercise of
a holder’s conversion right in accordance with the
indenture and the continuation of such default for 10 days;
•
our failure to provide notice of the occurrence of a fundamental
change when required under the indenture;
•
default by us in the performance, or breach of any of the other
covenants contained in the indenture with respect to the notes;
such default having continued for 60 days after written
notice as provided pursuant to the indenture;
•
failure to pay any final judgments in excess of
$20.0 million in the aggregate by us or one of our
subsidiaries and such judgments are not paid, discharged or
stayed for a period of 60 days;
•
default by us in the payment of an aggregate principal amount
exceeding $20.0 million of any indebtedness, such default
having occurred after the expiration of any applicable grace
period and having resulted in the acceleration of the maturity
of such indebtedness, but only if such indebtedness is not
discharged or such acceleration is not rescinded or annulled,
such default having continued for a period of 10 days after
written notice as provided pursuant to the indenture; and
•
specified events of bankruptcy, insolvency or reorganization, or
court appointment of a receiver, liquidator or trustee for the
Company or any Significant Subsidiary (as defined in
Article I,
Rule 1-02
of
Regulation S-X,
promulgated under the Securities Act) or any of their respective
property.
If an event of default under the indenture occurs and is
continuing, then in every such case the trustee or the holders
of not less than 25% in principal amount of the outstanding
notes may declare the principal amount of all of the notes to be
due and payable immediately by written notice thereof to the
Company, and to the trustee if given by the holders. However, at
any time after such a declaration of acceleration with respect
to the notes has been made, but before a judgment or decree for
payment of the money due has been obtained by the trustee, the
holders of a majority in principal amount of the outstanding
notes may rescind and annul such declaration and its
consequences if:
•
we shall have paid or deposited with the trustee all required
payments of the principal of, and interest (including additional
interest, if any) on, the notes, plus required fees, expenses,
disbursements and advances of the trustee; and
all events of default, other than the nonpayment of accelerated
principal of, or interest (including additional interest, if
any) on, the notes have been cured or waived as provided in the
indenture.
The indenture also provides that the holders of a majority in
principal amount of the outstanding notes may waive any past
default and its consequences, except a default:
•
in the payment of the principal of, or interest (including
additional interest, if any) on, the notes;
•
our failure to convert any note in accordance with the
provisions of the indenture; or
•
in respect of a covenant or provision contained in the indenture
that cannot be modified or amended without the consent of the
holder of each note affected thereby.
The trustee will be required to give notice to the holders of
notes within 90 days of a default under the indenture
unless such default has been cured or waived; provided, however,
that the trustee may withhold notice to the holders of any
default (except a default in the payment of the principal of, or
interest (including additional interest, if any) on, the notes)
if specified responsible officers of the trustee consider such
withholding to be in the interest of such holders.
Subject to the provisions in the indenture relating to its
duties in case of default, the trustee is under no obligation to
exercise any of its rights or powers under the indenture at the
request or direction of any holders of the notes then
outstanding under the indenture, unless such holders shall have
offered to the trustee thereunder reasonable security or
indemnity. The holders of a majority in principal amount of the
outstanding notes shall have the right to direct the time,
method and place of conducting any proceeding for any remedy
available to the trustee in respect of the notes, or of
exercising any trust or power conferred upon the trustee in
respect of the notes. However, the trustee may refuse to follow
any direction which is in conflict with any law or the
indenture, which may involve the trustee in personal liability
or which may be unduly prejudicial to the holders of the notes
not joining therein, but may take any other action deemed proper
by the trustee which is not inconsistent with such direction.
Within 120 days after the close of each fiscal year, the
Company must deliver to the trustee a certificate, signed by one
of several specified officers of the Company, stating whether or
not such officer has knowledge of any default applicable to the
notes under the indenture and, if so, specifying each such
default and the nature and status thereof.
Modifications and amendments of the indenture may be made only
with the consent of the holders of a majority in principal
amount of all outstanding debt securities affected by such
modification or amendment (voting together as a single class);
provided, however, that no such modification or amendment may,
without the consent of the holders of each such note affected
thereby:
•
change the stated maturity of the principal of, or any
installment of interest (including additional interest, if any)
on, the notes;
•
reduce the principal amount of, or the rate of interest
(including additional interest, if any) on, or change the timing
or reduce the amount payable on redemption of, the notes;
•
make any change that impairs or adversely affects the rights of
a holder to convert notes in accordance with the indenture;
•
change the place of payment, or the coin or currency, for
payment of principal of, or interest (including additional
interest, if any) on, the notes;
•
impair the right to institute suit for the enforcement of any
payment on or with respect to notes or the delivery of the
conversion value as required by the indenture upon a conversion
of notes;
•
reduce the above stated percentage in principal amount of
outstanding notes necessary to modify or amend the indenture, to
waive compliance with specified provisions thereof or specified
defaults and consequences thereunder or to reduce the quorum or
voting requirements set forth in the indenture; or
modify any of the foregoing provisions or any of the provisions
relating to the waiver of some past defaults or some covenants,
except to increase the required percentage to effect such action
or to provide that specified other provisions may not be
modified or waived without the consent of the holders of each
note affected thereby.
A note shall be deemed outstanding if it has been authenticated
and delivered under the indenture unless, among other things,
such note has matured or been canceled, converted, redeemed or
repurchased.
The indenture provides that the holders of not less than a
majority in principal amount of outstanding notes have the right
to waive compliance by the Company with specified covenants in
the indenture in respect of the notes.
In addition, the provisions set forth above under
“— Subordination of the Notes” may not be
amended or modified without the written consent of the holders
of at least 75% in aggregate principal amount of the notes then
outstanding if such amendment would materially adversely affect
the rights of the holders of the notes.
Modifications and amendments of the indenture may be made by the
Company and the trustee without the consent of any holder, when
authorized by the board of directors of the Company, at any
time, in a form satisfactory to the trustee, for certain
purposes, including the following:
•
to evidence the succession or addition of another person to the
Company as obligor under the indenture;
•
to add to the covenants of the Company for the benefit of the
holders or to surrender any right or power conferred upon the
Company in the indenture;
•
to add events of default for the benefit of the holders of all
the notes;
•
to permit or facilitate the issuance of notes in uncertificated
form, provided, that such action shall not adversely affect the
interests of the holders in any material respect;
•
to secure the notes;
•
to evidence and provide for the acceptance of appointment by a
successor trustee and to add to or change any of the provisions
of the indenture as is necessary to provide for or facilitate
the administration of the trusts under the indenture by more
than one trustee;
•
to provide for conversion rights of holders of notes if any
reclassification or change of common shares or any
consolidation, merger or sale of all or substantially all of the
property or assets of the Company occurs;
•
to cure any ambiguity, defect or inconsistency in the
indenture; or
•
to supplement any of the provisions of the indenture to the
extent necessary to permit or facilitate defeasance and
discharge of the notes under the indenture, provided that such
action shall not adversely affect the interests of the holders
in any material respect.
The indenture contains provisions for convening meetings of the
holders of the notes. A meeting may be called at any time by the
trustee, and also, upon request, by the Company, in any such
case upon notice given as provided in the indenture. Except for
any consent that must be given by the holder of each note
affected by specified modifications and amendments of the
indenture, any resolution presented at a meeting or adjourned
meeting duly reconvened at which a quorum is present will be
permitted to be adopted by the affirmative vote of the holders
entitled to vote a majority in aggregate principal amount of the
outstanding debt securities represented at that meeting;
provided, however, that, except as referred to above, any
resolution with respect to any request, demand, authorization,
direction, notice, consent, waiver or other action that may be
made, given or taken by the holders of a specified percentage,
which is less than a majority, in principal amount of the
outstanding debt securities may be adopted at a meeting or
adjourned meeting duly reconvened at which a quorum is present
by the affirmative vote of the holders of such specified
percentage in principal amount of the outstanding debt
securities. Any resolution passed or decision taken at any
meeting of holders of debt securities, including the notes, duly
held in accordance with the indenture will be binding on all
holders of
such debt securities, whether or not present or represented at
the meeting. The quorum at any meeting of holders of the debt
securities, including the notes, called to adopt a resolution,
and at any reconvened meeting, will be persons holding or
representing a majority in principal amount of such outstanding
debt securities; provided, however, that if any action is to be
taken at such meeting with respect to a consent or waiver which
may be given by the holders of not less than a specified
percentage in principal amount of the outstanding debt
securities, the persons holding or representing such specified
percentage in principal amount of such outstanding debt
securities will constitute a quorum.
Notwithstanding the foregoing provisions, if any action is to be
taken at a meeting of holders of the notes with respect to any
request, demand, authorization, direction, notice, consent,
waiver or other action that the indenture expressly provides may
be made, given or taken by the holders of a specified percentage
in principal amount of all outstanding notes affected thereby,
or of the holders of such series and one or more additional
series:
•
there shall be no minimum quorum requirement for such
meeting; and
•
the principal amount of such outstanding notes that vote in
favor of such request, demand, authorization, direction, notice,
consent, waiver or other action shall be taken into account in
determining whether such request, demand, authorization,
direction, notice, consent, waiver or other action has been
made, given or taken under the indenture.
Discharge,
Defeasance and Covenant Defeasance
We may satisfy and discharge our obligations under the indenture
by delivering to the trustee for cancellation all outstanding
notes or by depositing with the trustee, the paying agent or the
conversion agent, if applicable, after the notes have become due
and payable, whether on the stated maturity date, any redemption
date or any repurchase date, or upon conversion or otherwise,
cash or common shares (as applicable under the terms of the
indenture) sufficient to pay all of the outstanding notes and
paying all other sums payable under the indenture.
Rule 144A
Information
If at any time we are not subject to the reporting requirements
of the Exchange Act, the Company will promptly furnish to the
holders, beneficial owners and prospective purchasers of the
notes or underlying common shares, upon their request, the
information required to be delivered pursuant to
Rule 144A(d)(4) of the Securities Act to facilitate the
resale of those notes or shares pursuant to Rule 144A.
Governing
Law
The indenture and the notes are governed by, and construed in
accordance with, the laws of the State of New York.
Trustee
The Bank of New York is the trustee, registrar, conversion
agent, bid solicitation agent and paying agent. If an event of
default occurs and is continuing, the trustee will be required
to use the degree of care and skill of a prudent man in the
conduct of his own affairs. The trustee will become obligated to
exercise any of its powers under the indenture at the request of
any of the holders of any notes only after those holders have
offered the trustee indemnity satisfactory to it.
If the trustee becomes one of our creditors, it will be subject
to limitations on its rights to obtain payment of claims or to
realize on some property received for any such claim, as
security or otherwise. The trustee is permitted to engage in
other transactions with us. If, however, it acquires any
conflicting interest, it must eliminate that conflict or resign.
We will provide to the trustee, upon request, within
15 days after we are required to file the same with the
SEC, copies of the annual reports and of the information,
documents and other reports (or copies of such portions of any
of the foregoing as the SEC may prescribe) which we are required
to file with the SEC pursuant to Section 13 or
Section 15(d) of the Exchange Act. If we are not required
to file information, documents or reports pursuant to either of
those sections, then we will provide to the trustee upon request
and to the SEC such reports as may be prescribed by the SEC at
such time.
Book-Entry
System
The notes have been issued in the form of one fully-registered
global note in book-entry form, which has been deposited with,
or on behalf of, The Depository Trust Company (“DTC”)
and registered in the name of DTC’s nominee,
Cede & Co. Except as set forth below, the global note
may not be transferred except as a whole by DTC to a nominee of
DTC or by a nominee of DTC to DTC or another nominee of DTC or
by DTC or any such nominee to a successor of DTC or a nominee of
such successor.
So long as DTC or its nominee is the registered owner of a
global note, DTC or its nominee, as the case may be, will be
considered the sole holder of the notes represented by such
global note for all purposes under the indenture and the
beneficial owners of the notes will be entitled only to those
rights and benefits afforded to them in accordance with
DTC’s regular operating procedures. Upon specified written
instructions of a participant in DTC, DTC will have its nominee
assist participants in the exercise of certain holders’
rights, such as demand for acceleration of maturity or an
instruction to the trustee. Except as provided below, owners of
beneficial interests in a global note will not be entitled to
have notes registered in their names, will not receive or be
entitled to receive physical delivery of notes in certificated
form and will not be considered the registered owners or holders
thereof under the indenture.
If (i) DTC is at any time unwilling or unable to continue
as depositary or if at any time DTC ceases to be a clearing
agency registered under the Exchange Act and a successor
depositary is not appointed by us within 90 days,
(ii) an Event of Default under the indenture relating to
the notes has occurred and is continuing or (iii) we, in
our sole discretion, determine at any time that the notes shall
no longer be represented by a global note, we will issue
individual notes in certificated form of the same series and
like tenor and in the applicable principal amount in exchange
for the notes represented by the global note. In any such
instance, an owner of a beneficial interest in a global note
will be entitled to physical delivery of individual notes in
certificated form of the same series and like tenor, equal in
principal amount to such beneficial interest and to have the
notes in certificated form registered in its name. Notes so
issued in certificated form will be issued in denominations of
$1,000 or any integral multiple thereof and will be issued in
registered form only, without coupons.
The following is based on information furnished by DTC:
DTC acts as securities depositary for the notes. The notes were
issued as fully-registered notes registered in the name of
Cede & Co. (DTC’s partnership nominee).
DTC, the world’s largest depositary, is a limited-purpose
trust company organized under the New York Banking Law, a
“banking organization” within the meaning of the New
York Banking Law, a member of the Federal Reserve System, a
“clearing corporation” within the meaning of the New
York Uniform Commercial Code, and a “clearing agency”
registered pursuant to the provisions of Section 17A of the
Exchange Act. DTC holds and provides asset servicing for over
2 million issues of U.S. and
non-U.S. equity
issues, corporate and municipal debt issues and money market
instruments from over 85 countries that DTC’s direct
participants deposit with DTC.
DTC also facilitates the post-trade settlement among direct
participants of sales and other securities transactions in
deposited securities, through electronic computerized book-entry
transfers and pledges between direct participants’
accounts. This eliminates the need for physical movement of
securities certificates. Direct participants include both U.S.
and
non-U.S. securities
brokers and dealers, banks, trust companies, clearing
corporations, and certain other organizations. DTC is a
wholly-owned subsidiary of The Depository Trust &
Clearing Corporation (“DTCC”). DTCC, in turn, is owned
by a number of direct
participants of DTC and members of the National Securities
Clearing Corporation, Government Securities Clearing
Corporation, MBS Clearing Corporation, and Emerging Markets
Clearing Corporation, as well as by The New York Stock Exchange,
Inc., the American Stock Exchange LLC and the National
Association of Securities Dealers, Inc. Access to the DTC system
is also available to others such as both U.S. and
non-U.S. securities
brokers and dealers, banks, trust companies and clearing
corporations that clear through or maintain a custodial
relationship with a direct participant, either directly or
indirectly. DTC has Standard & Poor’s highest
rating: AAA. The DTC rules applicable to its participants are on
file with the SEC. More information about DTC can be found at
www.dtcc.com.
Purchases of the notes under the DTC system must be made by or
through direct participants, which will receive a credit for the
notes on DTC’s records. The beneficial interest of each
actual purchaser of each note is in turn to be recorded on the
direct and indirect participants’ records. Beneficial
owners will not receive written confirmation from DTC of their
purchase. Beneficial owners are, however, expected to receive
written confirmations providing details of the transaction, as
well as periodic statements of their holdings, from the direct
or indirect participant through which the beneficial owner
entered into the transaction. Transfers of beneficial interests
in the notes are to be accomplished by entries made on the books
of direct and indirect participants acting on behalf of
beneficial owners. Beneficial owners will not receive
certificates representing their beneficial interests in notes,
except in the event that use of the book-entry system for the
notes is discontinued. The laws of some states require that
certain persons take physical delivery in definitive form of
securities which they own. Such limits and such laws may impair
the ability of such persons to own, transfer or pledge
beneficial interests in a global note.
To facilitate subsequent transfers, all notes deposited by
direct participants with DTC will be registered in the name of
DTC’s partnership nominee, Cede & Co. or such
other name as may be requested by an authorized representative
of DTC. The deposit of the notes with DTC and their registration
in the name of Cede & Co. or such other nominee do not
effect any change in beneficial ownership. DTC has no knowledge
of the actual beneficial owners of the notes; DTC’s records
reflect only the identity of the direct participants to whose
accounts the notes will be credited, which may or may not be the
beneficial owners. The direct and indirect participants will
remain responsible for keeping account of their holdings on
behalf of their customers.
Conveyance of notices and other communications by DTC to direct
participants, by direct participants to indirect participants,
and by direct participants and indirect participants to
beneficial owners will be governed by arrangements among them,
subject to any statutory or regulatory requirements as may be in
effect from time to time. Beneficial owners of the notes may
wish to take certain steps to augment the transmission to them
of notices of significant events with respect to the notes, such
as redemption, tenders, defaults, and proposed amendments to the
security documents. For example, beneficial owners of the notes
may wish to ascertain that the nominee holding the notes for
their benefit has agreed to obtain and transmit notices to
beneficial owners. In the alternative, beneficial owners may
wish to provide their names and addresses to the registrar of
the notes and request that copies of the notices be provided to
them directly. Any such request may or may not be successful.
Neither DTC nor Cede & Co. (nor any other DTC nominee)
will consent or vote with respect to the notes unless authorized
by a direct participant in accordance with DTC’s
procedures. Under its usual procedures, DTC mails an Omnibus
Proxy to us as soon as possible after the regular record date.
The Omnibus Proxy assigns Cede & Co.’s consenting
or voting rights to those direct participants to whose accounts
the notes are credited on the record date (identified in a
listing attached to the Omnibus Proxy).
We will pay principal of and interest on the notes in
same-day
funds to the trustee and from the trustee to DTC, or such other
nominee as may be requested by an authorized representative of
DTC. DTC’s practice is to credit direct participants’
accounts on the applicable payment date in accordance with their
respective holdings shown on DTC’s records upon DTC’s
receipt of funds and corresponding detail information. Payments
by participants to beneficial owners will be governed by
standing instructions and customary practices, as is the case
with securities held for the accounts of customers in bearer
form or registered in “street name,” and will be the
responsibility of these participants and not of us, the
trustee, DTC, or any other party, subject to any statutory or
regulatory requirements that may be in effect from time to time.
Payment of principal and interest to Cede & Co., or
such other nominee as may be requested by an authorized
representative of DTC, is the responsibility of us or the
trustee, disbursement of such payments to direct participants is
the responsibility of DTC, and disbursement of such payments to
the beneficial owners is the responsibility of the direct or
indirect participants.
We will send any redemption notices to DTC. If less than all of
the notes are being redeemed, DTC’s practice is to
determine by lot the amount of the interest of each direct
participant in such issue to be redeemed.
A beneficial owner of notes shall give notice to elect to have
its notes purchased or tendered, through its participant, to the
conversion agent and shall effect delivery of such notes by
causing the direct participant to transfer the
participant’s interest in notes, on DTC’s records, to
the conversion agent. The requirement for physical delivery of
notes in connection with an optional tender or a mandatory
purchase will be deemed satisfied when the ownership rights in
the notes are transferred by direct participants on DTC’s
records and followed by a book-entry credit of tendered notes to
the conversion agent’s DTC account.
DTC may discontinue providing its services as securities
depositary for the notes at any time by giving us reasonable
notice. Under such circumstances, if a successor securities
depositary is not obtained, we will print and deliver
certificated notes. We may decide to discontinue use of the
system of book-entry transfers through DTC (or a successor
securities depositary). In that event, we will print and deliver
certificated notes.
We and the trustee have no responsibility or liability for any
aspect of the records relating to or payments made on account of
the beneficial interests in a global note, or for maintaining,
supervising or reviewing any records relating to such beneficial
interests.
The information in this section concerning DTC and DTC’s
system has been obtained from sources that we believe to be
reliable, but we take no responsibility for its accuracy.
Registration
Rights; Additional Interest
We and the initial purchasers entered into a registration rights
agreement. Pursuant to the registration rights agreement, we
agreed:
•
to file with the SEC or otherwise have on file with the SEC, by
the 120th day after the date we first issue the notes, a
shelf registration statement to cover resales of registrable
securities (as described below) by the holders who satisfy
certain conditions and provide the information we describe below
for use with the shelf registration statement;
•
to use our reasonable best efforts to cause the shelf
registration statement to be declared effective under the
Securities Act, as promptly as practicable but in any event by
the 180th day after the date we first issue the notes or
otherwise make available for use by selling securityholders an
effective shelf registration statement no later than such
date; and
•
to use our reasonable best efforts to keep the shelf
registration statement continuously effective under the
Securities Act, until there are no registrable securities
outstanding.
However, the registration rights agreement permits us to
prohibit offers and sales of registrable securities pursuant to
the shelf registration statement for a period not to exceed an
aggregate of 45 days in any three-month period and not to
exceed an aggregate of 135 days in any
12-month
period, under certain circumstances and subject to certain
conditions. We refer to any such period during which we may
prohibit offers and sales as a “suspension period.” We
need not specify the nature of the event giving rise to a
suspension in any notice to holders of the registrable
securities of the existence of such a suspension.
“Registrable securities” means each outstanding
note and any common share delivered upon conversion of the notes
until the earlier of:
•
the date the notes and any such common shares have been
effectively registered under the Securities Act and disposed of
in accordance with the shelf registration statement; and
•
the date when the notes or any such common shares are eligible
for sale by a holder that is not an affiliate of ours pursuant
to Rule 144(k) under the Securities Act or any similar
provision then in effect.
Holders of registrable securities must deliver to us certain
information to be used in connection with, and to be named as
selling securityholders in, the shelf registration statement in
order to have their registrable securities included in the shelf
registration statement. Any holder that does not duly complete
and deliver a questionnaire or provide the information it
requires will not be named as a selling securityholder in the
shelf registration statement and will not be permitted to sell
any registrable securities held by that holder pursuant to the
shelf registration statement. We cannot assure you that we will
be able to maintain an effective and current shelf registration
statement as required. The absence of an effective shelf
registration statement is likely to limit a holder’s
ability to sell its registrable securities and adversely affect
the price, if any, at which it may sell its registrable
securities.
If:
•
the shelf registration statement is not filed with the SEC by
the 120th day after the first issue date of the notes;
•
the shelf registration statement has not been declared effective
under the Securities Act by the 180th day after the first
issue date of the notes or an effective shelf registration
statement covering resales of the registrable securities is
otherwise not made available for use by selling securityholders
by such date;
•
a holder supplies the questionnaire described below after the
effective date of the shelf registration statement or the date
after which we first make available an effective shelf
registration statement for use by selling securityholders, and
we fail to supplement or amend the shelf registration statement,
or file a new shelf registration statement, in accordance with
the terms of the registration rights agreement, in order to add
such holder as a selling securityholder;
•
the shelf registration statement is filed and has become
effective under the Securities Act, but then ceases to be
effective (without being succeeded immediately by an additional
shelf registration statement that is filed and immediately
becomes effective) or usable for the offer and sale of
registrable securities, other than as a result of a requirement
to file a post-effective amendment or prospectus supplement to
the registration statement in order to make changes to the
information in the prospectus forming part of the shelf
registration statement regarding the selling securityholders or
the plan of distribution, and (1) we do not cure the lapse
of effectiveness or usability of the registration statement
within 15 business days (or if a suspension period is then in
effect, the 15th business day following the expiration of
such suspension period) by a post-effective amendment,
prospectus supplement or report filed pursuant to the Exchange
Act, or (2) if suspension periods exceed an aggregate of
45 days in any three-month period or an aggregate of
135 days in any
12-month
period; or
•
we fail to name as a selling securityholder, in the shelf
registration statement or any amendment to the shelf
registration statement, at the time it becomes effective under
the Securities Act, or in any prospectus relating to the shelf
registration statement, at the time we file the prospectus or,
if later, the time the related shelf registration statement or
amendment becomes effective under the Securities Act or pursuant
to such other appropriate filing under the Exchange Act as
provided herein, any holder that is entitled to be so named as a
selling securityholder within the prescribed time periods,
then we will pay additional interest to each holder of notes
then outstanding that constitute registrable securities who has
provided to us the required selling securityholder information.
We refer to each event described in the bullet points above as a
“registration default.”
Additional interest will accrue on the notes then outstanding
that constitute registrable securities, from, and including, the
day following the registration default to, but excluding, the
day on which the registration default has been cured. Additional
interest will be paid semi-annually in arrears, with the first
semi-annual payment due on the first interest payment date, as
applicable, following the date on which such additional interest
begins to accrue, and will accrue at a rate per year equal to:
•
0.25% of the principal amount to, and including, the
90th day following such registration default; and
•
0.50% of the principal amount from and after the 91st day
following such registration default.
In no event will additional interest accrue at a rate per year
exceeding 0.50%.
We will not pay any additional interest on any note after it has
been converted for common shares. If a note ceases to be
outstanding during a registration default, we will prorate the
additional interest to be paid with respect to that note. In
addition, in no event will additional interest be payable in
connection with a registration default relating to a failure to
register the common stock deliverable upon a conversion of the
notes. For the avoidance of doubt, if we fail to register both
the notes and the common stock deliverable upon conversion of
the notes, the additional interest will be payable in connection
with the registration statement relating to the failure to
register the notes.
So long as a registration default continues, we will pay
additional interest in cash on January 15 and July 15 of each
year to each holder who is entitled to receive additional
interest in respect of registrable securities of which the
holder was the holder of record at the close of business on the
immediately preceding January 1 and July 1, respectively.
Following the cure of a registration default, additional
interest will cease to accrue with respect to that registration
default. In addition, no additional interest will accrue after
the period we must keep the shelf registration statement
effective under the Securities Act or on any note that ceases to
be a registrable security. However, we will remain liable for
any previously accrued additional interest. Other than our
obligation to pay additional interest, we will not have any
liability for damages with respect to a registration default on
any registrable securities.
We have agreed in the registration rights agreement to give
notice to all holders of the effectiveness of the initial shelf
registration statement by release through a reputable national
newswire service. A holder of registrable securities that does
not provide us with a completed questionnaire or the information
called for by it on or prior to the date the initial shelf
registration statement becomes effective may not be named as a
selling securityholder in the shelf registration statement when
it becomes effective and may not able to use the shelf
registration statement to resell registrable securities.
Similarly, if we designate an effective shelf registration
statement for use by selling securityholders, a holder of
registrable securities that does not provide us with a completed
questionnaire or the information called for by it on or prior to
the date of the initial prospectus made available to selling
securityholders may not be named as a selling securityholder in
the prospectus and may not able to use the shelf registration
statement to resell registrable securities. However, in either
case, such a holder of registrable securities may thereafter
provide us with a completed questionnaire, following which we
will use our reasonable best efforts to file, as promptly as
reasonably practicable after the date we receive the completed
questionnaire, but in any event within 15 business days after
that date (except as described below), file a supplement to the
prospectus relating to the shelf registration statement or, if
required, file a post-effective amendment, a new shelf
registration statement or other appropriate filing under the
Exchange Act in order to permit resales of such holder’s
registrable securities. However, if we receive the questionnaire
during a suspension period, or we initiate a suspension period
within 15 business days after we receive the questionnaire, then
we will, except as described below, make the filing within 15
business days after the end of the suspension period. We will
not be required to file more than three such prospectus
supplements for all holders during a fiscal quarter or more than
three such post-effective amendments or other filings for all
holders during any
180-day
period. If we file a post-effective amendment or a new shelf
registration statement, then we will use our reasonable best
efforts to cause the post-effective amendment or new shelf
registration statement to be declared effective under the
Securities Act, as promptly as practicable, but in any event by
the 60th day in the case of a post-effective amendment and
the 60th day in the case of a
new shelf registration statement, after the date the
registration rights agreement requires us to file the
post-effective amendment or new registration statement, as
applicable.
If a holder does not deliver a duly completed questionnaire on
or before the effective date of the original shelf registration
statement or on or before the date the prospectus is first made
available for use by selling securityholders, the holder could
experience significant additional delay. To the extent that any
holder of registrable securities identified in the shelf
registration statement is a broker-dealer, or is an affiliate of
a broker-dealer that did not acquire its registrable securities
in the ordinary course of its business or that at the time of
its purchase of registrable securities had an agreement or
understanding, directly or indirectly, with any person to
distribute the registrable securities, we understand that the
SEC may take the view that such holder is, under the SEC’s
interpretations, an “underwriter” within the meaning
of the Securities Act.
The specific provisions relating to the registration described
above are contained in the registration rights agreement, which
we filed previously with the SEC and which is incorporated
herein by reference. This summary of the registration rights
agreement is not complete and is qualified in its entirety by
reference to the registration rights agreement. This prospectus
is part of the shelf registration statement filed pursuant to
the terms of the registration rights agreement.
Certain
Definitions
Set forth below is a summary of certain of the defined terms
used in the indenture. Reference is made to the indenture for
the full definition of all such terms, as well as any other
terms used herein for which no definition is provided.
“Amended and restated credit agreement”means
that certain Credit Agreement dated as of December 29, 2004
as among Orbital Sciences Corporation, as borrower, the Lenders
referred to therein, Bank of America, NA as Administrative Agent
and Wachovia Bank, National Association, as Documentation Agent,
as amended, restated, modified, renewed, refunded, replaced,
restructured or refinanced (including any agreement to increase
the amount of available borrowings thereunder, extend the
maturity thereof and add additional borrowers or guarantors) in
whole or in part from time to time under the same or any other
agent, lender or group of lenders.
“Capital lease obligation”means, at the time
any determination is to be made, the amount of the liability in
respect of a capital lease that would at that time be required
to be capitalized on a balance sheet in accordance with GAAP.
“Capital stock”means:
(1) in the case of a corporation, corporate stock;
(2) in the case of an association or business entity, any
and all shares, interests, participations, rights or other
equivalents (however designated) of corporate stock;
(3) in the case of a partnership or limited liability
company, partnership or membership interests (whether general or
limited); and
(4) any other interest or participation that confers on a
person the right to receive a share of the profits and losses
of, or distributions of assets of, the issuing person.
“Credit facilities”means one or more debt
facilities or agreements (including, without limitation, the
amended and restated credit agreement) or commercial paper
facilities, in each case with banks or other institutional
lenders or investors providing for revolving credit loans, term
loans, receivables financing (including through the sale of
receivables to such lenders or to special purpose entities
formed to borrow from such lenders against such receivables) or
letters of credit, in each case, as amended, restated, modified,
renewed, refunded, replaced, restructured or refinanced
(including any agreement to increase the amount of available
borrowings thereunder, extend the maturity thereof and add
additional borrowers or guarantors) in whole or in part from
time to time under the same or any other agent, lender or group
of lenders.
“Designated senior indebtedness”means
(i) any indebtedness outstanding under the amended and
restated credit agreement and (ii) any other senior
indebtedness the principal amount of which is $5 million or
more and that has been designated by us as “designated
senior indebtedness.”
“Equity interests”means capital stock and all
warrants, options or other rights to acquire capital stock (but
excluding any debt security that is convertible into, or
exchangeable for, capital stock).
“GAAP”means accounting principles generally
accepted in the United States set forth in the opinions and
pronouncements of the Accounting Principles Board of the
American Institute of Certified Public Accountants and
statements and pronouncements of the Financial Accounting
Standards Board or in such other statements by such other entity
as have been approved by a significant segment of the accounting
profession, which are in effect from time to time.
“Guarantee”means a guarantee other than by
endorsement of negotiable instruments for collection in the
ordinary course of business, direct or indirect, in any manner
including, without limitation, by way of a pledge of assets or
through letters of credit or reimbursement agreements in respect
thereof, of all or any part of any indebtedness.
“Hedging obligations”means, with respect to
any specified person, the obligations of such person under:
(1) interest rate swap agreements, interest rate cap
agreements and interest rate collar agreements; and
(2) other agreements or arrangements designed to protect
such person against fluctuations in interest rates.
“Indebtedness”means, with respect to any
specified person, any indebtedness of such person, whether or
not contingent:
(1) in respect of borrowed money;
(2) evidenced by bonds, notes, debentures or similar
instruments or letters of credit (or reimbursement agreements in
respect thereof);
(3) in respect of banker’s acceptances;
(4) representing capital lease obligations;
(5) representing the balance deferred and unpaid of the
purchase price of any property, except any such balance that
constitutes an accrued expense or trade payable; or
(6) representing any hedging obligations,
if and to the extent any of the preceding items (other than
letters of credit and hedging obligations) would appear as a
liability upon a balance sheet of the specified person prepared
in accordance with GAAP.
In addition, the term “indebtedness” includes all
indebtedness of others secured by a lien on any asset of the
specified person (whether or not such indebtedness is assumed by
the specified person) and, to the extent not otherwise included,
the guarantee by the specified person of any indebtedness of any
other person.
Notwithstanding anything in the foregoing to the contrary,
indebtedness shall not include trade payables or accrued
expenses for property or services incurred in the ordinary
course of business. The amount of any indebtedness outstanding
as of any date shall be:
(1) the accreted value of the indebtedness, in the case of
any indebtedness issued with original issue discount; and
(2) the principal amount of the indebtedness, together with
any interest on the indebtedness that is more than 30 days
past due, in the case of any other indebtedness.
“Lien”means, with respect to any asset, any
mortgage, lien, pledge, charge, security interest or encumbrance
of any kind in respect of such asset, whether or not filed,
recorded or otherwise perfected under
applicable law, including any conditional sale or other title
retention agreement, any lease in the nature thereof, any option
or other agreement to sell or give a security interest in and
any filing of or agreement to give any financing statement under
the Uniform Commercial Code (or equivalent statutes) of any
jurisdiction.
“Obligations”means any principal, interest,
penalties, fees, indemnifications, reimbursements, costs,
expenses, damages and other liabilities payable under the
documentation governing any indebtedness.
“Senior indebtedness”means:
(1) all indebtedness of the Company outstanding under
credit facilities and all hedging obligations with respect
thereto;
(2) the Company’s existing 9% Senior Notes due
2011;
(3) any other indebtedness of the Company, unless the
instrument under which such indebtedness is incurred expressly
provides that it is on a parity with or subordinated in right of
payment to the notes; and
(4) all obligations with respect to the items listed in the
preceding clauses (1), (2) and (3).
Notwithstanding anything to the contrary in the preceding,
senior indebtedness will not include:
(1) any liability for federal, state, local or other taxes
owed or owing by the Company; or
“Senior subordinated indebtedness”means any
indebtedness of the Company that specifically provides that such
indebtedness is to have the same rank as the notes in right of
payment and is not subordinated by its terms in right of payment
to any indebtedness or other obligation of the Company which is
not senior indebtedness.
“Subordinated indebtedness”means any
indebtedness of a party (whether outstanding on the date of the
indenture or thereafter incurred) that is subordinate or junior
in right of payment to the notes pursuant to a written agreement
to that effect.
“Subsidiary”means, with respect to any
specified person:
(1) any corporation, association, limited liability company
or other business entity of which more than 50% of the total
voting power of shares of capital stock entitled (without regard
to the occurrence of any contingency) to vote in the election of
directors, managers or trustees of the corporation, association
or other business entity is at the time owned or controlled,
directly or indirectly, by that person or one or more of the
other subsidiaries of that person (or a combination
thereof); and
(2) any partnership (a) the sole general partner or
the managing general partner of which is such person or a
subsidiary of such person or (b) the only general partners
of which are that person or one or more subsidiaries of that
person (or any combination thereof).
The following summary of certain provisions of our common
stock and preferred stock does not purport to be complete and is
subject to, and qualified in its entirety by, the provisions of
our Restated Certificate of Incorporation, as amended (the
“Certificate”), and by the provisions of applicable
law.
Common
Stock
Our Board of Directors has authorized 200,000,000 shares of
common stock, par value $.01 per share, of which
59,280,756 shares were issued and outstanding as of
March 22, 2007. Holders of our common stock are entitled to
one vote per share on all matters to be voted on by
shareholders, including the election of directors. Subject to
the rights of holders of any preferred stock that may be issued,
holders of common stock are entitled to receive such dividends
as may be declared from time to time by our Board of Directors
from funds legally available therefor. Upon liquidation,
dissolution or
winding-up
of the Company, the holders of our common stock will be entitled
to share ratably all assets available for distribution to
shareholders after payment of liabilities, subject to prior
preemptive or conversion rights or other subscription rights.
There are no redemption or sinking fund provisions applicable to
the common stock.
Preferred
Stock
Our Board of Directors has authorized 10,000,000 shares of
preferred stock, $.01 par value per share, none of which
are issued or outstanding. Our Board of Directors is authorized,
without any further action by the shareholders, to provide for
the issuance of the unissued shares of preferred stock and to
determine the rights, preferences, privileges and restrictions
of the unissued preferred stock.
Limitation
of Liability
Section 102(b)(7) of the Delaware General Corporation Law
(the “DGCL”) authorizes corporations to limit or
eliminate the personal liability of directors to corporations
and their stockholders for monetary damages for breach of
directors’ fiduciary duty of care. Although
Section 102(b)(7) does not change directors’ duty of
care, it enables corporations to limit available relief to
equitable remedies such as injunction or rescission. Our
Certificate limits the liability of directors to the company or
its stockholders to the full extent permitted by the DGCL.
Certain
Statutory Provisions
Section 203 of the DGCL provides, in general, that a
stockholder acquiring more than 15% of the outstanding voting
shares of a corporation subject to the statute (an
“Interested Stockholder”), but less than 85% of such
shares, may not engage in certain “Business
Combinations” with the corporation for a period of three
years subsequent to the date on which the stockholder became an
Interested Stockholder unless (i) prior to such time the
corporation’s board of directors approved either the
Business Combination or the transaction in which the stockholder
became an Interested Stockholder or (ii) at or subsequent
to such time the Business Combination is approved by the
corporation’s board of directors and authorized by a vote
of at least two-thirds of the outstanding voting stock of the
corporation not owned by the Interested Stockholder.
Section 203 defines the term “Business
Combination” to encompass a wide variety of transactions
with or caused by an Interested Stockholder in which the
Interested Stockholder receives or could receive a benefit on
other than a pro rata basis with other stockholders, including
mergers, certain asset sales, certain issuances of additional
shares to the Interested Stockholder, transactions with the
corporation which increase the proportionate interest of the
Interested Stockholder or a transaction in which the Interested
Stockholder receives certain other benefits.
Section 102(b)(3) of the DGCL provides that no stockholder
shall have any preemptive right to subscribe to an additional
issue of stock or to any security convertible into such stock
unless, and except to the extent that, such right is expressly
granted to him in the certificate of incorporation. Our
Certificate does not grant
stockholders such preemptive rights. Accordingly, our
stockholders do not have preemptive rights to subscribe for
additional issuances of common stock or for any security
convertible into such stock.
Transfer
Agent
Computershare Trust Company, N.A. is the transfer agent and
registrar for the common stock.
The following discussion is a summary of the United States
federal income tax considerations relevant to the purchase,
ownership and disposition of the notes or our common stock
acquired upon conversion of the notes. This discussion is for
general information purposes only and does not purport to be a
complete analysis of all potential tax effects. The discussion
is based upon the Internal Revenue Code of 1986 (the
“Code”), United States Treasury Regulations, Internal
Revenue Service (“IRS”) rulings and pronouncements and
judicial decisions now in effect, all of which are subject to
change at any time, possibly with retroactive effect. The
discussion does not address all of the federal income tax
consequences that may be relevant to a holder in light of such
holder’s particular circumstances or to holders subject to
special rules, such as certain financial institutions, insurance
companies, dealers in securities, traders that elect to use
mark-to-market
accounting, partnerships (or entities treated as partnerships
for United States tax purposes), S corporations, tax-exempt
organizations, persons holding the notes as part of a straddle,
hedge or conversion transaction, persons who have ceased to be
United States citizens or resident aliens, and persons with a
functional currency other than the United States dollar.
Moreover, the effect of any applicable state, local or foreign
tax laws or of United States federal tax law other than income
taxation is not discussed. The discussion deals only with notes
held as “capital assets” within the meaning of
Section 1221 of the Code.
As used herein, “U.S. Holder” means a beneficial
owner of the notes (or, as applicable, of shares of our common
stock received on conversion of the notes) that is:
(1) a citizen or resident of the United States,
(2) a corporation (or other entity treated as a corporation
for United States federal income tax purposes), created or
organized in or under the laws of the United States or a
political subdivision thereof,
(3) an estate, the income of which is subject to United
States federal income taxation regardless of its source, or
(4) a trust if (i) (A) a United States court is
able to exercise primary supervision over the administration of
the trust and (B) one or more United States persons have
authority to control all substantial decisions of the trust, or
(ii) the trust was in existence on August 20, 1996 and
has elected to continue to be treated as a United States person.
As used herein, a
“Non-U.S. Holder”
means a beneficial owner of the notes other than a partnership
(or any entity treated as a partnership for United States tax
purposes) who or that is not a U.S. Holder.
If a partnership (including for this purpose any entity treated
as a partnership for United States tax purposes) is a beneficial
owner of the notes, the treatment of a partner in the
partnership will generally depend upon the status of the partner
and upon the activities of the partnership. A holder of notes
that is a partnership, and partners in such partnership, should
consult their tax advisors about the United States federal
income tax consequences of holding and disposing of the notes.
Based on currently applicable authorities, we believe that the
notes constitute indebtedness for United States federal income
tax purposes. This determination is not, however, binding on the
IRS. Persons considering the purchase of a note should consult
their own tax advisors as to the foregoing. The remainder of
this discussion assumes that the notes will constitute
indebtedness for United States federal income tax purposes.
We have not sought and will not seek any rulings from the IRS
with respect to the matters discussed below. There can be no
assurance that the IRS will not take a different position
concerning the tax consequences of the purchase, ownership or
disposition of the notes or that any such position would not be
sustained.
Prospective investors are urged to consult their own tax
advisors with regard to the application of the tax consequences
discussed below to their particular situations as well as the
application of any state, local, foreign or other tax laws,
including gift and estate tax laws.
The stated interest on the notes generally will be taxable to a
U.S. Holder as ordinary income at the time that it is paid
or accrued, in accordance with the U.S. Holder’s
method of accounting for federal income tax purposes. Such
income will be United States-source income.
Market
Discount
If a U.S. Holder purchases a note for an amount that is
less than its stated redemption price at maturity (generally,
the sum of all payments required under the note other than
payments of stated interest), then the U.S. Holder will be
treated as having purchased the note at a “market
discount,” unless the market discount is less than a de
minimis amount (one-fourth of one percent of the stated
redemption price at maturity of the note times the number of
complete years to maturity after the U.S. Holder acquires
the note).
Under the market discount rules, a U.S. Holder will be
required to treat any partial principal payment on a note, or
any gain realized on the sale, conversion, repurchase,
retirement, or other disposition of a note, as ordinary income
to the extent of the lesser of (i) the amount of the
payment or realized gain or (ii) the market discount that
has not previously been included in income and is treated as
having accrued on such note at the time of such payment or
disposition. Market discount will be considered to accrue
ratably during the period from the date of acquisition to the
maturity date of the note, unless the U.S. Holder elects to
accrue market discount on a constant yield basis. Once made,
such an election may be revoked only with the consent of the IRS
and, therefore, should only be made in consultation with a tax
advisor.
A U.S. Holder may be required to defer the deduction of all
or a portion of the interest paid or accrued on any indebtedness
incurred or maintained to purchase or carry a note with market
discount until the maturity of the note or certain earlier
dispositions, because a current deduction is only allowed to the
extent that the interest expense exceeds the portion of market
discount allocable to the days during the taxable year in which
the note was held by the taxpayer. A U.S. Holder may elect
to include market discount in income currently as it accrues (on
either a ratable or constant yield basis), in which case the
rules described above regarding the treatment as ordinary income
of gain upon the disposition of the note and upon the receipt of
certain cash payments and regarding the deferral of interest
deductions will not apply. Generally, currently included market
discount is treated as ordinary interest for U.S. federal
income tax purposes. Such an election will apply to all debt
instruments with market discount acquired by the
U.S. Holder on or after the first day of the taxable year
to which the election applies and may be revoked only with the
consent of the IRS. The election, therefore, should only be made
in consultation with a tax advisor.
Upon the conversion of a note into cash and common stock, any
accrued market discount on the note not previously included in
income will be carried over to the common stock received upon
conversion of the note, and any gain recognized upon the
disposition of the common stock will be treated as ordinary
income to the extent of the accrued market discount.
Amortizable
Bond Premium
If a U.S. Holder purchases a note for an amount that is
greater than the stated redemption price at maturity of the
note, then the U.S. Holder will be considered to have
purchased the note with “amortizable bond premium.” In
general, amortizable bond premium with respect to any
convertible debt instrument (such as a note) will be equal in
amount to the excess, if any, of the tax basis (reduced as set
forth in the following sentence) over the sum of all amounts
payable on the debt instrument other than stated interest. For
this purpose only, a U.S. Holder’s tax basis in a
convertible debt instrument is reduced by an amount equal to the
value of the U.S. Holder’s option to convert the
convertible debt instrument for other property (such as our
shares of common stock); the value of this option may be
determined under any reasonable method. However, in the case of
a debt instrument that may be redeemed prior to maturity at the
option of the issuer (such as the notes), the amount of
amortizable bond premium is determined by substituting the first
date on which the debt instrument may be redeemed (the
“redemption date”) for the maturity date and the
applicable redemption price
on the redemption date for the amount payable at maturity, if
the result would maximize the U.S. Holder’s yield to
maturity (i.e., result in a smaller amount of amortizable bond
premium properly allocable to the period before the redemption
date). If the issuer does not in fact exercise its right to
redeem the debt instrument on the applicable redemption date,
then the debt instrument will be treated (solely for purposes of
the amortizable bond premium rules) as having matured and then
as having been reissued for the U.S. Holder’s
“adjusted acquisition price,” which is an amount equal
to the U.S. Holder’s basis in the debt instrument (as
determined under the applicable Treasury regulations), less the
sum of (i) any amortizable bond premium allocable to prior
accrual periods and (ii) any payments previously made on
the debt instrument (other than payments of qualified stated
interest). The debt instrument deemed to have been reissued will
again be subject to the amortizable bond premium rules with
respect to the remaining dates on which the debt instrument is
redeemable.
A U.S. Holder may elect to amortize bond premium on a debt
instrument over the remaining term of the debt instrument. Once
made, the election applies to all taxable debt instruments then
owned and thereafter acquired by the U.S. Holder on or
after the first day of the taxable year to which the election
applies, and may be revoked only with the consent of the IRS.
The election, therefore, should only be made in consultation
with a tax advisor. In general, a U.S. Holder amortizes
bond premium by offsetting the stated interest allocable to an
accrual period with the bond premium allocable to the accrual
period, which is determined under a constant yield method
pursuant to the applicable Treasury Regulations. If the bond
premium allocable to an accrual period exceeds the stated
interest allocable to such period, the excess is treated by the
U.S. Holder as a bond premium deduction. The bond premium
deduction for each accrual period is limited to the amount by
which the U.S. Holder’s total interest inclusions on
the debt instrument in prior accrual periods exceed the total
amount treated by the U.S. Holder as a bond premium
deduction on the debt instrument in prior accrual periods. Any
amounts not deductible in an accrual period may be carried
forward to the next accrual period and treated as bond premium
allocable to that period.
Election
to Include All Interest in Income Using a Constant Yield
Method
All U.S. Holders may generally, upon election, include in
income all interest (including stated interest, acquisition
discount, original issue discount, de minimis original issue
discount, market discount, de minimis market discount, and
unstated interest, as adjusted by any amortizable bond premium
or acquisition premium) that accrues on a debt instrument by
using the constant yield method applicable to original issue
discount, subject to certain limitations and exceptions. Because
this election will affect how the U.S. Holder treats debt
instruments other than the notes, it should be made only in
consultation with a tax advisor.
Conversion
of Notes
If a U.S. Holder converts a note and we deliver solely cash
in satisfaction of our obligation, such cash payment will be
treated as a sale of the note by the U.S. Holder as
described below under “Sale, Redemption or Other Taxable
Disposition of Notes or Common Stock.”
If a U.S. Holder converts a note and we deliver a
combination of our common stock and cash (other than cash
received solely in lieu of a fractional share of our common
stock), the tax treatment to the U.S. Holder is uncertain.
The conversion might be treated as a recapitalization, in which
case the U.S. Holder would be required to recognize any
gain (but not loss) realized, but only to the extent such gain
does not exceed the amount of cash received (other than cash
received in lieu of a fractional share
and/or cash
attributable to accrued but unpaid interest). The
U.S. Holder’s tax basis in the common stock received
in the conversion (including any basis allocable to a fractional
share deemed received) would be equal to such
U.S. Holder’s adjusted tax basis in the converted
notes, reduced by any cash received in the conversion (other
than cash received in lieu of a fractional share
and/or cash
attributable to accrued but unpaid interest) and increased by
any gain recognized on the conversion (other than gain realized
as a result of cash received in lieu of a fractional share).
Alternatively, the conversion might be treated as in part a
conversion into common stock and in part a payment in redemption
of the notes. In that event, the cash payment (other than cash
received in lieu of a
fractional share
and/or cash
attributable to accrued but unpaid interest) would be treated as
proceeds from a sale of a portion of the note, as described
below, under “Sale, Redemption or Other Taxable Disposition
of Notes or Common stock.” The U.S. Holder’s
adjusted tax basis in the note would be allocated pro rata
between the common stock received (including any fractional
share treated as received) and the portion of the note that is
treated as sold for cash (other than cash received in lieu of a
fractional share).
U.S. Holders are urged to consult their tax advisors with
respect to the United States federal income tax consequences
resulting from the exchange of notes into a combination of cash
and common stock.
Cash received in lieu of a fractional share of common stock upon
conversion of the notes into common stock will generally be
treated as a payment in exchange for the fractional share of
common stock treated as received by you rather than as a
dividend. Accordingly, the receipt of cash in lieu of a
fractional share of common stock generally will, subject to the
discussion above regarding market discount, result in capital
gain or loss measured by the difference between the cash
received for the fractional share and the
U.S. Holder’s adjusted tax basis allocable to the
fractional share. This capital gain or loss will be taxable as
described below under “— Sale, Redemption or
Other Taxable Disposition of Notes or Common Stock.” Cash
received that is attributable to accrued interest not previously
included in income will be taxable as ordinary interest income.
The holding period for any common stock received in the
conversion (including any fractional share treated as received)
will include the holding period for the converted note.
Distributions
on Common Stock
Distributions, if any, on our common stock will constitute
dividends for United States federal income tax purposes to the
extent of our current or accumulated earnings and profits as
determined under United States federal income tax principles and
will be included in a U.S. Holder’s income as ordinary
income as they are paid. Dividends on our common stock paid to
certain U.S. Holders (including individuals) may qualify
for preferential United States federal income tax rates. To the
extent that a U.S. Holder receives distributions on shares
of common stock that exceed our current and accumulated earnings
and profits, such distributions will be treated first as a
non-taxable return of capital reducing the
U.S. Holder’s tax basis in the shares of common stock
(but not below zero). Any such distributions in excess of the
U.S. Holder’s tax basis in the shares of common stock
will generally be treated as capital gain. Subject to applicable
limitations, dividends paid to U.S. Holders that are
corporations will qualify for the dividends-received deduction.
Sale,
Redemption or Other Taxable Disposition of Notes or Common
Stock
Except as set forth above under “Conversion of Notes,”
a U.S. Holder will recognize gain or loss upon the sale,
retirement, redemption or other taxable disposition of the notes
or common stock in an amount equal to the difference between:
(1) the amount of cash and the fair market value of other
property received in exchange therefor (other than amounts
attributable to accrued but unpaid stated interest with respect
to a note, which will be taxable as ordinary income to the
extent not previously included in income) and
(2) the U.S. Holder’s adjusted tax basis in such
note or common stock. A U.S. Holder’s tax basis in a
note generally will be the price paid for the note, increased by
the amount of any accrued market discount previously included in
the U.S. Holder’s income, and decreased by the amount
of any amortizable bond premium previously taken into account by
the U.S. Holder.
Subject to the discussion above regarding market discount, gain
or loss recognized will generally be capital gain or loss, and
such capital gain or loss will generally be long-term capital
gain or loss if the note has been held by the U.S. Holder
for more than one year and otherwise will be a short-term
capital gain or loss. Long-term capital gain for non-corporate
taxpayers (including individuals) is subject to reduced rates of
United States federal income taxation. The deductibility of
capital losses is subject to limitations.
We intend to treat the possibility that we will pay additional
interest as described above under “Description of
Notes — Registration Rights; Additional Interest”
as a remote or incidental contingency, within the meaning of
applicable Treasury regulations. In the unlikely event that an
additional amount becomes payable, we believe that they will be
taxable to a U.S. Holder as ordinary interest income at the
time that they are paid or accrued in accordance with such
holder’s method of accounting for tax purposes. Our
determination that there is a remote likelihood of paying
additional amounts on the notes is binding on each
U.S. Holder unless the U.S. Holder explicitly
discloses in the manner required by applicable Treasury
regulations that its determination is different from ours. The
IRS, however, may take a different position, which could affect
the timing of a U.S. Holder’s income with respect to
such additional amounts.
Adjustment
of Conversion Price
The conversion rate of the notes will be adjusted if we
distribute cash with respect to shares of our common stock and
in certain other circumstances. See “Description of the
Notes — Conversion Rights — Conversion Rate
Adjustments” and “— Make Whole Upon
Fundamental Change.” Under Section 305(c) of the Code
and the applicable Treasury Regulations, an increase in the
conversion rate as a result of a taxable distribution to our
common stockholders generally will result in a deemed
distribution to U.S. Holders holding our notes. Other
adjustments in the conversion rate (or failures to make such
adjustments) that have the effect of increasing your
proportionate interest in our assets or earnings may have the
same result. Any such adjustment would result in dividend income
(subject to a possible dividends received deduction in the case
of corporate holders) to the extent of our current or
accumulated earnings and profits, if, and to the extent that, it
increases the proportionate interest of a holder of notes in the
fully diluted common stock, whether or not such holder ever
exercises its conversion privilege. Moreover, if there is not a
full adjustment to the conversion ratio of the notes to reflect
a stock dividend or other event increasing the proportionate
interest of the holders of outstanding common stock in our
assets or earnings and profits, then such increase in the
proportionate interest of the holders of the common stock
generally will be treated as a distribution to such holders,
taxable as dividend income (subject to a possible dividends
received deduction in the case of corporate holders) to the
extent of our current or accumulated earnings and profits.
Therefore, U.S. Holders may recognize income in the event
of a deemed distribution even though they may not receive any
cash or property. Holders of notes are advised to consult with
their tax advisors with respect to the potential tax
consequences of such constructive distributions.
Information
Reporting and Backup Withholding
Information reporting requirements apply to certain payments of
principal, interest and dividends made to, and to the proceeds
of sales by, non-corporate U.S. Holders. Also, certain
non-corporate U.S. Holders may be subject to backup
withholding on such payments, currently at a gross rate of 28%,
where the holder (1) fails to furnish its TIN (taxpayer
identification number), which, for an individual, would
ordinarily be his or her social security number,
(2) furnishes an incorrect TIN, (3) is notified by the
IRS that it has failed to properly report payments of interest
or dividends, or (4) under certain circumstances, fails to
certify, under penalties of perjury, that it has furnished a
correct TIN and that it has not been notified by the IRS that it
is subject to backup withholding. Holders should consult their
own tax advisors regarding their qualification for exemption
from backup withholding and the procedure for obtaining such an
exemption, if applicable.
Backup withholding is not an additional tax. Any amounts
withheld under the backup withholding rules from a payment to a
U.S. Holder will be allowed as a refund or a credit against
such U.S. Holder’s federal income tax liability,
provided that the requisite procedures are followed.
Non-U.S. Holders
Interest
Subject to the discussion below concerning backup withholding,
interest (including additional amounts as described under
“U.S. Holders — Additional Interest”)
paid to a
Non-U.S. Holder
will not be subject to United
States federal income or withholding tax, provided that
(i) such interest is not effectively connected with the
conduct of a trade or business in the United States by the
Non-U.S. Holder
(or, if an income tax treaty applies, is not attributable to a
permanent establishment maintained by the
Non-U.S. Holder
in the United States) and (ii) such
Non-U.S. Holder
(1) does not actually or constructively own 10% or more of
the total combined voting power of all classes of our stock,
(2) is not a controlled foreign corporation that is related
to us through stock ownership, and (3) satisfies certain
certification requirements. Such certification requirements will
be met if (x) the
Non-U.S. Holder
provides its name and address, and certifies on IRS
Form W-8BEN
(or successor form), under penalties of perjury, that it is not
a United States person or (y) a securities clearing
organization or certain other financial institutions holding the
note on behalf of the
Non-U.S. Holder
certifies on IRS
Form W-8IMY
(or successor form), under penalties of perjury, that such
certification has been received by it, and furnishes us or our
paying agent with a copy thereof. In addition, we or our paying
agent must not have actual knowledge or reason to know that the
beneficial owner of the note is a United States person. If these
requirements are not met, a
Non-U.S. Holder
will be subject to United States withholding tax at a rate of
30% (or lower treaty rate, if applicable) on interest payments.
Distributions
on common stock
Dividends paid (and any deemed dividends resulting from certain
adjustments or failure to make adjustments to the conversion
rate, as discussed above under
“U.S. Holders — Adjustment of Conversion
Price”) on our common stock to a
Non-U.S. Holder
generally will be subject to a 30% United States federal
withholding tax (or, if applicable, a lower treaty rate)
provided that such dividends are not effectively connected with
the conduct of a trade or business in the United States by the
Non-U.S. Holder
(or, if an income tax treaty applies, are not attributable to a
permanent establishment maintained by the
Non-U.S. Holder
in the United States) and certain certification requirements are
met.
If a dividend is deemed received by a
Non-U.S. Holder
and does not include any cash from which we may satisfy our
withholding obligations, we may, at our option, set off any such
payment against payments of cash and common stock payable on the
notes (or, in certain circumstances, against any payments on the
common stock).
Sale,
Redemption or Other Taxable Disposition of Notes or Common
Stock
Subject to the discussion below regarding backup withholding,
any gain realized by any
Non-U.S. Holder
upon the sale, exchange or redemption of a note will not be
subject to United States federal income tax, provided that
(i) such gain is not effectively connected with the conduct
of a trade or business in the United States by the
Non-U.S. Holder
(and, if an income tax treaty applies, is not attributable to a
permanent establishment maintained by the
Non-U.S. Holder
in the United States), (ii) the
Non-U.S. Holder
is not an individual who is present in the United States for a
total of 183 days or more during the taxable year in which
the gain is realized and certain other conditions are satisfied
and (iii) we are not treated as a United States real
property holding corporation for United States federal income
tax purposes.
United
States Business
Any interest, dividends or gain (including gain recognized as a
result of the conversion of the notes) that is effectively
connected with a
Non-U.S. Holder’s
trade or business in the United States (and, if an income tax
treaty applies, is attributable to a United States permanent
establishment maintained by such
Non-U.S. Holder)
will be subject to the graduated tax applicable to
U.S. Holders, and with respect to corporate
Non-U.S. Holders,
may also be subject to an additional branch profits tax at a
rate of 30% or a lower rate under an applicable income tax
treaty. In addition, any such interest and dividend income will
not be subject to withholding tax if the
Non-U.S. Holder
delivers to us a properly executed IRS
Form W-8ECI
(or successor form) in order to claim an exemption from
withholding tax.
Non-U.S. Holders
should consult their tax advisors with respect to other United
States tax consequences of the ownership and disposition of
notes and common stock into which the notes may be converted.
To the extent that you receive cash upon conversion of a note,
you generally would be subject to the rules described under
“— Non-U.S. Holders —
Sale, Redemption or Other Taxable Disposition of Notes or Common
Stock.” Cash attributable to accrued but unpaid interest
would generally be taxed as described above under
“— Non-U.S. Holders —
Interest.”
Information
Reporting and Backup Withholding
We are generally required to backup withhold, currently at a
gross rate of 28%, on certain payments of principal and interest
made to, and to the proceeds of sales by,
Non-U.S. Holders.
However, this backup withholding tax will not apply to payments
to a
Non-U.S. Holder
if such
Non-U.S. Holder
satisfies the certification requirements described above under
“— Interest,” provided that the payor does
not have actual knowledge or reason to know that the
certification is incorrect and the holder is a United States
person. Information reporting requirements may apply with
respect to interest payments on the notes and dividend payments
on the common stock, in which event the amount of interest or
dividends paid and tax withheld (if any) with respect to each
Non-U.S. Holder
will be reported annually to the IRS.
The payment of the proceeds from the disposition of notes to or
through the United States office of any broker, United States or
foreign, will be subject to information reporting and possible
backup withholding unless the owner certifies as to its
non-U.S. status
under penalties of perjury or otherwise establishes an
exemption, provided that the broker does not have actual
knowledge that the holder is a United States person or that the
conditions of any other exemption are not, in fact, satisfied.
The payment of the proceeds from the disposition of a note to or
through a
non-United
States office of a
non-United
States broker that is not a United States related person will
not be subject to information reporting or backup withholding.
For this purpose, a “United States related person” is:
(1) a “controlled foreign corporation” for United
States federal income tax purposes,
(2) a foreign person 50% or more of whose gross income from
all sources for the three-year period ending with the close of
its taxable year preceding the payment (or for such part of the
period that the broker has been in existence) is derived from
activities that are effectively connected with the conduct of a
United States trade or business or
(3) a foreign partnership that, at any time during its
taxable year, is owned 50% or more (by income or capital
interest) by United States persons or is engaged in the conduct
of a United States trade or business.
In the case of the payment of proceeds from the disposition of
notes to or through a
Non-United
States office of a broker that is a United States related
person, the regulations require information reporting on the
payment unless the broker has documentary evidence in its files
that the owner is a
Non-U.S. Holder
and the broker has no knowledge to the contrary. Backup
withholding will not apply to payments made through foreign
offices of a broker that is a United States person or a United
States related person (absent actual knowledge that the payee is
a United States person).
Backup withholding is not an additional tax. Any amounts
withheld under the backup withholding rules from a payment to a
Non-U.S. Holder
will be allowed as a refund or a credit against such
Non-U.S. Holder’s
federal income tax liability, provided that the requisite
procedures are followed.
We originally issued the notes to Wachovia Capital Markets, LLC
and Banc of America Securities LLC, the initial purchasers of
the notes, in a private placement in December 2006. The notes
were immediately resold by the initial purchasers to persons
reasonably believed by the initial purchasers to be qualified
institutional buyers within the meaning of Rule 144A under
the Securities Act in transactions exempt from registration
under the Securities Act. Selling securityholders, including
their transferees, pledgees or donees or their successors, may
from time to time offer and sell the notes and the common shares
into which the notes are convertible in certain circumstances,
pursuant to this prospectus. Our registration of the notes and
the common shares issuable, in certain circumstances, upon
conversion of the notes does not necessarily mean that the
selling securityholders will sell all or any of the notes or the
common shares. Unless set forth below, none of the selling
securityholders has had a position, office or any other material
relationship with us, or any of our predecessors or affiliates,
within the past three years.
The following table sets forth certain information concerning
the principal amount of notes beneficially owned by each selling
securityholder and the number of common shares that may be
offered from time to time by each selling securityholder under
this prospectus. The information is based on information
provided to us by or on behalf of the selling securityholders on
or prior to March 23, 2007. The number of common shares
issuable upon conversion of the notes shown in the table below
represents the maximum number of common shares issuable upon
conversion of the notes assuming conversion of the full amount
of notes held by each holder at the initial conversion rate of
40.8513 common shares per $1,000 principal amounts of the notes.
This conversion rate is subject to adjustments in certain
circumstances. Because the selling securityholders may offer all
or some portion of the notes or common shares issuable upon
conversion of the notes, we have assumed for purposes of the
table below that the named selling securityholders will sell all
of the notes or convert all of the notes and sell all of the
common shares issuable upon conversion of the notes offered
pursuant to this prospectus. In addition, the selling
securityholders identified below may have sold, transferred or
otherwise disposed of all or a portion of their notes since the
date on which they provided the information regarding their
notes in transactions exempt from the registration requirements
of the Securities Act. Information about the selling
securityholders may change over time. Any changed information
given to us by the selling securityholders will be set forth in
prospectus supplements if and when necessary or, if appropriate,
a post-effective amendment to the registration statement of
which this prospectus is a part. Because the selling
securityholders may offer all or some portion of their notes or
the underlying common shares from time to time, we cannot
estimate the amount of notes or underlying common shares that
will be held by the selling securityholders upon the termination
of any particular offering. See “Plan of Distribution”
for further information.
Other Shares of
Our Common
Percentage of
Number of
Stock
Shares of
Aggregate
Shares of
Beneficially
Common
Principal
Common Stock
Owned
Stock
Amount of
Issuable Upon
Before the
Beneficially
Notes
Percentage of
Conversion of
Offering and
Outstanding
Beneficially
Notes
the Notes That
Assumed to be
Following the
Owned That
Outstanding
May be Sold
Owned Following
Offering
Name†
May be Sold
(1)
(2)(3)
the Offering
(4)
AHFP Context
$
220,000
—
8,987
—
—
Alcon Laboratories
$
124,000
—
5,065
—
—
Altma Fund SICAV PLC in
respect of the Grafton Sub Fund
$
490,000
—
20,017
—
—
Arlington County Employees
Retirement System
$
178,000
—
7,271
—
—
British Virgin Islands Social
Security Board
$
41,000
—
1,674
—
—
CALAMOS Market Neutral Income
Fund — CALAMOS Investment Trust
All other holders of notes or
future transferees of such holders(5)
$
9,785,000
6.807
%
399,729
—
—
†
The selling securityholders identified with a crosshatch have
identified that they are, or are affiliates of, registered
broker-dealers. These selling securityholders have represented
that they acquired their securities in the ordinary course of
business and in the open market, and, at the time of the
acquisition of the securities, had no agreements or
understandings, directly or indirectly, with any person to
distribute the securities. To the extent that we become aware
that any such selling securityholders did not acquire its
securities in the ordinary course of business or did have such
an agreement or understanding, we will file a post-effective
amendment to registration statement of which this prospectus is
a part to designate such person as an “underwriter”
within the meaning of the Securities Act.
(1)
Unless otherwise noted, none of these selling securityholders
beneficially owns 1% or more of the outstanding notes.
(2)
The number of common shares shown in the table above assumes
conversion of the full amount of notes, and represents the
maximum number of common shares issuable upon conversion of all
of the holder’s notes at the initial conversion rate of
40.8513 common shares per $1,000 principal amount of the notes.
Because securityholders will, upon conversion, receive cash and
not common shares up to the full principal amount of the notes,
the numbers of common shares shown in the table above are
indicative of value only and not actual common shares issuable.
Moreover, this conversion rate is subject to adjustment as
described under “Description of Notes —
Conversion Rights.” As a result, the number of common
shares issuable upon conversion of the notes may increase or
decrease in the future. Under the terms of the indenture,
fractional shares will not be issued upon conversion of the
notes. Cash will be paid in lieu of a fractional common share
upon conversion of the notes.
(3)
Each share is accompanied by a preferred share purchase right
pursuant to a rights agreement between Orbital Sciences
Corporation and BankBoston N.A., as rights agent.
(4)
Calculated based on
Rule 13d-3
of the Exchange Act, using 59,280,756 shares of common
stock outstanding as of March 22, 2007. In calculating
these percentages for each holder of notes, we also treated as
outstanding that number of common shares issuable upon
conversion of that holder’s notes. However, we did not
assume the conversion of any other holder’s notes in
calculating these percentages. Based on the
59,280,756 shares of common stock outstanding as of
March 22, 2007, unless otherwise noted, none of
these selling securityholders would beneficially own 1% or more
of the outstanding common shares following the sale of
securities in the offering.
(5)
Assumes that any other holder of notes or any future transferee
of any such holder does not beneficially own any common shares
other than the common shares issuable upon conversion of the
notes at the initial conversion rate.
The selling securityholders and their successors, which includes
their pledgees, donees, partnership distributees and other
transferees receiving the notes or common shares from the
selling securityholders in non-sale transfers, may sell the
notes and the underlying common shares directly to purchasers or
through underwriters, broker-dealers or agents. Underwriters,
broker-dealers or agents may receive compensation in the form of
discounts, concessions or commissions from the selling
securityholders or the purchasers. These discounts, concessions
or commissions may be in excess of those customary in the types
of transactions involved.
The notes and the underlying common shares may be sold in one or
more transactions at:
•
fixed prices that may be changed;
•
prevailing market prices at the time of sale;
•
prices related to the prevailing market prices;
•
varying prices determined at the time of sale; or
•
negotiated prices.
These sales may be effected in a variety of transactions, which
may involve crosses or block transactions, including the
following:
•
on any national securities exchange or quotation service on
which the notes or our common shares may be listed or quoted at
the time of sale, including the New York Stock Exchange in the
case of our common shares;
•
in the
over-the-counter-market;
•
in transactions otherwise than on these exchanges or services or
in the
over-the-counter
market (privately negotiated transactions);
•
ordinary brokerage transactions and transactions in which a
broker-dealer solicits purchasers;
•
block trades in which the broker-dealer will attempt to sell the
offered shares as agent but may position and resell a portion of
the block as principal to facilitate the transaction;
•
purchases by a broker-dealer as principal and resale by the
broker-dealer for its account pursuant to this prospectus;
•
through the writing and exercise of options (including the
issuance of derivative securities), whether these options or
such other derivative securities are listed on an options or
other exchange or otherwise;
•
through the settlement of short sales; or
•
through any combination of the foregoing, or by any legally
available means.
Selling securityholders may enter into hedging transactions with
broker-dealers or other financial institutions which may in turn
engage in short sales of the notes or the underlying common
shares and deliver these securities to close out short
positions. In addition, the selling securityholders may sell the
notes and the common shares short and deliver the notes and
underlying common shares to close out short positions or loan or
pledge the notes or the underlying common shares to
broker-dealers or other financial institutions that in turn may
sell such securities. Selling securityholders may also enter
into option or other transactions with broker-dealers or other
financial institutions that require the delivery to the
broker-dealers or other financial institutions of the notes or
the underlying common shares or enter into transactions in which
a broker-dealer makes purchases as a principal for resale for
its own account or through other types of transactions.
Selling securityholders may decide not to sell all or a portion
of the notes and the underlying common shares offered by them
pursuant to this prospectus or may decide not to sell notes or
the underlying common shares under this prospectus. In addition,
selling securityholders may sell or transfer their notes and
common
shares issuable upon conversion of the notes other than by means
of this prospectus. In particular, any securities covered by
this prospectus that qualify for sale pursuant to Rule 144,
Rule 144A or Regulation S under the Securities Act may
be sold thereunder, rather than pursuant to this prospectus.
The aggregate proceeds to the selling securityholders from the
sale of the notes or underlying common shares will be the
purchase price of the notes or common shares less any discounts
and commissions. A selling securityholder reserves the right to
accept and, together with their agents, to reject any proposed
purchase of notes or common shares to be made directly or
through agents. We will not receive any of the proceeds from
this offering.
In order to comply with the securities laws of some
jurisdictions, if applicable, the holders of notes and common
shares into which the notes are convertible may sell in some
jurisdictions through registered or licensed broker dealers. In
addition, under certain circumstances in some jurisdictions, the
holders of notes and the common shares into which the notes are
convertible may be required to register or qualify the
securities for sale or comply with an available exemption from
the registration and qualification requirements.
Our common shares are listed on the New York Stock Exchange
under the symbol “ORB.” We do not intend to apply for
listing of the notes on any securities exchange or for quotation
through Nasdaq. The notes originally issued in the private
placement are eligible for trading on The
PORTALsm
Market. However, notes sold pursuant to this prospectus will no
longer be eligible for trading on The
PORTALsm
Market. Accordingly, no assurance can be given as to the
development of liquidity or any trading market for the notes.
The selling securityholders and any underwriters, broker-dealers
or agents who participate in the distribution of the notes and
the underlying common shares may be deemed to be
“underwriters” within the meaning of the Securities
Act. As a result, any profits on the sale of the notes or the
underlying common shares by selling securityholders and any
discounts, commissions or concessions received by any such
broker-dealers or agents may be deemed to be underwriting
discounts and commissions under the Securities Act. If the
selling securityholders were deemed to be underwriters, the
selling securityholders will be subject to the prospectus
delivery requirements of the Securities Act and may be subject
to liabilities including, but not limited to, those of
Sections 11, 12 and 17 of the Securities Act and
Rule 10b-5
under the Exchange Act.
If the notes and the underlying common shares are sold through
underwriters or broker-dealers, the selling securityholders will
be responsible for underwriting discounts or commissions or
agent’s commissions.
Any selling securityholder who is a “broker-dealer”
may be deemed to be an “underwriter” within the
meaning of Section 2(11) of the Securities Act. As a
result, each such selling securityholder is an underwriter in
connection with the sale of the notes or the common shares
issuable upon conversion of the notes covered by this
prospectus. Such selling securityholders have informed us that
they have purchased their notes in the open market and in the
ordinary course of business, not directly from us, and we are
not aware of any underwriting plan or agreement,
underwriters’ or dealers’ compensation, or passive
market-making or stabilization transactions involving the
purchase or distribution of these securities by such
securityholders.
The selling securityholders and any other persons participating
in the distribution of the notes or underlying common shares
will be subject to the Exchange Act. The Exchange Act rules
include, without limitation, Regulation M, which may limit
the timing of purchases and sales of any of the notes and the
underlying common shares by the selling securityholders and any
such other person. In addition, Regulation M of the
Exchange Act may restrict the ability of any person engaged in
the distribution of the notes and the underlying common shares
to engage in market making activities with respect to the
particular notes and underlying common shares being distributed
for a period of up to five business days prior to the
commencement of such distribution. This may affect the
marketability of the notes and the underlying common shares and
the ability to engage in market making activities with respect
to the notes and the underlying common shares.
If required, the specific notes or common shares to be sold, the
names of the selling securityholders, the respective purchase
prices and public offering prices, the names of any agent,
dealer or underwriter and any applicable commissions or
discounts with respect to a particular offer will be set forth
in an accompanying
prospectus supplement or, if appropriate, a post-effective
amendment to the registration statement of which this prospectus
is a part.
We entered into a registration rights agreement for the benefit
of the holders of the notes to register the notes and the common
shares into which the notes are convertible under applicable
federal securities laws under specific circumstances and
specific times. Under the registration rights agreement, the
selling securityholders and we have agreed to indemnify each
other and our respective controlling persons against, and in
certain circumstances to provide contribution with respect to,
specific liabilities in connection with the offer and sale of
the notes and the common shares, including liabilities under the
Securities Act. We will pay substantially all of the expenses
incident to the registration of the notes and the common shares,
except that the selling securityholders will pay all
brokers’ commissions and, in connection with an
underwritten offering, if any, underwriting discounts and
commissions. See “Description of Notes —
Registration Rights; Additional Interest” above.
Hogan & Hartson L.L.P. will pass upon certain legal
matters with respect to the notes and the common shares issuable
upon conversion of the notes, as well as certain federal income
tax matters.
The financial statements and management’s assessment of the
effectiveness of internal control over financial reporting
(which is included in Management’s Report on Internal
Control over Financial Reporting) incorporated in this
prospectus by reference to the Annual Report on
Form 10-K
for the year ended December 31, 2006 have been so
incorporated in reliance on the report of PricewaterhouseCoopers
LLP, an independent registered public accounting firm, given on
the authority of said firm as experts in auditing and accounting.
The following table sets forth the costs and expenses payable by
us in connection with the issuance and registration of the
securities being registered. All amounts except the SEC
registration fee are estimated.
SEC Registration Fee
$
4,413.13
Accounting Fees and Expenses
$
7,500.00
Legal Fees and Expenses
$
75,000.00
Printing Expenses
$
10,000.00
Total
$
96,913.13
Item 15.
Indemnification
of Directors and Officers
Under Section 145 of the Delaware General Corporation Law
(“DGCL”), a corporation may indemnify its directors,
officers, employees and agents and its former directors,
officers, employees and agents and those who serve, at the
corporation’s request, in such capacities with another
enterprise, against expenses (including attorneys’ fees),
as well as judgments, fines and settlements in nonderivative
lawsuits, actually and reasonably incurred in connection with
the defense of any action, suit or proceeding in which they or
any of them were or are made parties or are threatened to be
made parties by reason of their serving or having served in such
capacity. The DGCL provides, however, that such person must have
acted in good faith and in a manner such person reasonably
believed to be in (or not opposed to) the best interests of the
corporation and, in the case of a criminal action, such person
must have had no reasonable cause to believe his or her conduct
was unlawful. In addition, the DGCL does not permit
indemnification in an action or suit by or in the right of the
corporation, where such person has been adjudged liable to the
corporation, unless, and only to the extent that, a court
determines that such person fairly and reasonably is entitled to
indemnity for costs the court deems proper in light of liability
adjudication. Indemnity is mandatory for present and former
directors and officers to the extent such director or officer
has been successful on the merits or otherwise in the defense of
any action, suit or proceeding or in the defense of a claim,
issue or matter therein.
Our Certificate contains provisions that provide that no
director of the Company shall be liable to the Company or its
stockholders for monetary damages for breach of fiduciary duty
as a director, except to the extent that exculpation from
liability is not permitted under the DGCL as in effect at the
time such liability is determined. The Certificate further
provides that Orbital shall, to the maximum extent permitted by
the DGCL as presently in effect (except for Section 145(f)
of the DGCL), indemnify and upon request, advance expenses to,
any person who is or was a party or is threatened to be made
party to any threatened, pending or completed action, suit,
proceeding or claim, whether civil, criminal, administrative or
investigative, by reason of the fact that such person is or was
or has agreed to be a director or officer of the Company or
while a director or officer is or was serving at the request of
the Company as a director, officer, partner, trustee, employee
or agent of any corporation, partnership, joint venture, trust
or other enterprise, provided, however, that the Company shall
not be required to indemnify or advance expenses to any person
in connection with any action, suit, proceeding, claim or
counterclaim initiated by or on behalf of such person.
The Company has also entered into substantially identical
indemnification agreements (the “Indemnification
Agreements”) with each of its directors and certain of its
officers and senior managers. The Indemnification Agreements,
among other things, provide for the indemnification of each
indemnitee against all expenses (including attorneys’
fees), as well as judgments, fines and settlements in
nonderivative lawsuits, actually and reasonably incurred by the
indemnitee because he or she was, is or is threatened to be made
a party to any completed, pending or threatened action, suit or
proceeding by reason of the fact that he or she was a director,
officer, employee or agent of the Company or any of its
affiliates, or was serving, at the Company’s request, in
such capacities with another enterprise. Under the
Indemnification Agreements, the indemnitee will be indemnified
so long as he or she acted in good faith and in a manner
reasonably believed by him or her to be
in or not opposed to the Company’s best interests and, in
the case of a criminal action, had no reasonable cause to
believe his or her conduct was unlawful. In addition, the
Indemnification Agreements do not permit indemnification in an
action or suit by or in the right of the Company, where such
indemnitee has been adjudged liable to the Company, unless, and
only to the extent that, the court in which such action was
brought determines that the indemnitee is entitled to be
indemnified. The Indemnification Agreements further provide that
the indemnification thereunder is not exclusive of any other
rights the indemnitee may have under the Certificate or any
agreement or vote of stockholders and that the Certificate may
not be amended to adversely affect the rights of the indemnitee.
We have also obtained directors and officers liability insurance
against certain liabilities, including liabilities under the
Securities Act.
(1) To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration
statement:
(i) To include any prospectus required by
Section 10(a)(3) of the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events
arising after the effective date of the registration statement
(or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change
in the information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than 20 percent change in the
maximum aggregate offering price set forth in the
“Calculation of Registration Fee” table in the
effective registration statement;
(iii) To include any material information with respect to
the plan of distribution not previously disclosed in the
registration statement or any material change to such
information in the registration statement;
Provided, however, that paragraphs (a)(1)(i),
(a)(1)(ii) and (a)(1)(iii) do not apply if the information
required to be included in a post-effective amendment by those
paragraphs is contained in reports filed with or furnished to
the Commission by the registrant pursuant to Section 13 or
Section 15(d) of the Securities Exchange Act of 1934 that
are incorporated by reference in the registration statement, or
is contained in a form of prospectus filed pursuant to
Rule 424(b) that is part of the registration statement.
(2) That, for the purpose of determining any liability
under the Securities Act of 1933, each such post-effective
amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial
bona fide offering thereof.
(3) To remove from registration by means of a
post-effective amendment any of the securities being registered
which remain unsold at the termination of the offering.
(4) That, for the purpose of determining liability under
the Securities Act of 1933 to any purchaser:
(A) Each prospectus filed by the registrant pursuant to
Rule 424(b)(3) shall be deemed to be part of the
registration statement as of the date the filed prospectus was
deemed part of and included in the registration
statement; and
(B) Each prospectus required to be filed pursuant to
Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration
statement in reliance on Rule 430B relating to an offering
made pursuant to Rule 415(a)(1)(i), (vii) or
(x) for the purpose of providing the information required
by Section 10(a) of the Securities Act of 1933 shall be
deemed to be part of and included in the registration statement
as of the earlier of the date such form of prospectus is first
used after effectiveness or the date of the first contract of
sale of securities in the offering described in the prospectus.
As provided in Rule 430B, for liability purposes of the
issuer and any person that is at that date an underwriter, such
date shall be deemed to be a new effective date of the
registration statement relating to the securities in the
registration statement to which the prospectus relates, and the
offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof. Provided,
however, that no statement made in a registration statement
or prospectus that is part of the registration statement or made
in a document incorporated or deemed incorporated by reference
into the registration statement or prospectus that is part of
the registration statement will, as to a purchaser with a time
of contract of sale prior to such effective date, supersede or
modify any statement that was made in the registration statement
or prospectus that was part of the registration statement or
made in any such document immediately prior to such effective
date.
(b) The undersigned registrant hereby undertakes that, for
purposes of determining any liability under the Securities Act
of 1933, each filing of the registrant’s annual report
pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (and, where applicable, each filing of an
employee benefit plan’s annual report pursuant to
Section 15(d) of the Securities Exchange Act of
1934) that is incorporated by reference in this
registration statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising
under the Securities Act of 1933 may be permitted to directors,
officers and controlling persons of the registrant pursuant to
the foregoing provisions, or otherwise, the registrant has been
advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as
expressed in the Securities Act of 1933 and is, therefore,
unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful
defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the
securities being registered, the registrant will, unless in the
opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Securities Act of 1933
and will be governed by the final adjudication of such issue.
Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on
Form S-3
and has duly caused this registration statement to be signed on
its behalf by the undersigned, thereunto duly authorized, in the
city of Dulles, Commonwealth of Virginia, on March 26, 2007.
ORBITAL SCIENCES CORPORATION
a Delaware Corporation
By:
/s/ David
W. Thompson
David W. Thompson
Chairman of the Board
and Chief Executive Officer
POWER OF
ATTORNEY
Each person whose signature appears below hereby constitutes and
appoints David W. Thompson and Susan Herlick, and each of them,
his or her true and lawful
attorney-in-fact
and agent, with full power of substitution and resubstitution
for him or her in any and all capacities, to sign any or all
amendments or post-effective amendments to this registration
statement, or any registration statement for the same offering
that is to be effective upon filing pursuant to Rule 462(b)
under the Securities Act of 1933, as amended (the
“Act”), and to file the same, with all exhibits and
other documents in connection therewith, with the Securities and
Exchange Commission, and to execute, deliver and file any other
documents and instruments in the undersigned’s name or on
the undersigned’s behalf which said
attorneys-in-fact
and agents, or either of them, may determine to be necessary or
advisable to comply with the Act and any rules or regulations
promulgated thereunder, granting unto said
attorneys-in-fact
and agents, and each of them, full power and authority to do and
perform each and every act and thing requisite and necessary in
connection with such matters and hereby ratifying and confirming
all that said
attorneys-in-fact
and agents, or either of them, or their substitutes, may
lawfully do or cause to be done by virtue of the power of
attorney granted hereby.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
Signature
Title
Date
/s/ David
W. Thompson
David
W. Thompson
Chairman of the Board and
Chief Executive Officer, Director
(Principal Executive Officer)
Form of Certificate of Common
Stock (incorporated by reference to Exhibit 4.1 to the
Company’s Registration Statement on
Form S-1
(File
Number 33-33453)
filed on February 9, 1990 and effective on April 24,
1990).
4
.2
Indenture dated as of
December 13, 2006, by and between Orbital Sciences
Corporation and The Bank of New York, as Trustee (incorporated
by reference to Exhibit 4.1 to the Company’s Current
Report on
Form 8-K
filed on December 13, 2006).